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Aging is the critical risk factor for many forms of cancer. We used the
mammary gland as a model system to study the impact of age on human
epithelia in which age is the greatest risk factor for cancer. Dysfunctional
progenitor and luminal cells with acquired basal cell properties accumulate
during aging for reasons that are not understood. We evaluated the
hypothesis that a novel effect of aging is a defective stem cell regulation by
the microenvironment. We identified Axl as a previously unappreciated
mammary stem cell marker involved in breast epithelial homeostasis and
breast cancer progression. We showed that Axl is a marker of a
subpopulation of cKit epithelial progenitors. These progenitors are tightly
regulated by the microenvironment, specifically the mechanical properties of
the niche. We observed that mechano-response mechanisms in cKit
progenitors are altered with age. Thus, tissue-level phenotypes of aging in
breast may arise in part due to alterations in the Hippo mechano-signal
transduction pathway that lead to reduced efficiency of YAP/TAZ activation.
Finally, using mass cytometry, we described the first high-dimensional
phenotypic heterogeneity in normal human mammary epithelial cells.
Computational analysis using unsupervised population partitioning identified
clusters of a specific subset of luminal cells that acquired a more basal
phenotype and accumulate with age. Moreover, distinct age-related
phenotypic signatures were detectable in cKit-progenitor cells, considered the
cell-of-origin for breast cancers. Here, we propose a model where reciprocal
interactions between the microenvironment and breast epithelial progenitors
are skewed during the aging process, leading to a decrease in breast tissue
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Aging is a universal trait that is observed across the evolutionary spectrum.
Owing to increased lifespan and declining fertility, the world population aged
over 60 is anticipated to reach 21.8% of the total population by 2050 (Lutz
et al., 2008). Our species continues to live longer than seen in recorded
history, but from a public health perspective, aging is also the critical risk
factor for a range of human pathologies, including neuro-degenerative diseases,
metabolic diseases and many forms of cancer (Holliday, 2004). Understanding
the molecular processes that deteriorate with age and that are responsible
for increased disease susceptibility is critical to reach the growing health care
needs of aging human populations.
Age is the greatest risk factor for breast cancer, but the reasons underlying
this association are unclear. Women over 55 years old account for 80% of new
breast cancer diagnoses and 75% of breast cancer–related deaths. Importantly,
the majority of these age-related breast cancers are of luminal subtype (Jenkins
et al., 2014). While there is undeniably a genetic component to all cancers,
the accumulation of mutations with age is insufficient to explain the age-
dependent increase in breast cancer incidence (LaBarge et al., 2015; Stephens
et al., 2012). However, there are a number of known changes in the breast
microenvironment (endocrine profiles, breast density, stromal composition)
that are unique to aging. Indeed, there are age-associated changes in normal
human mammary stem and progenitor cells that correlate with an increased
potential for malignant transformation.
A major barrier to study the aging process is a lack of available model systems.
In this introduction, we evaluate the different common models developed with
their strengths and limitations. We discuss the possibility of a novel theory
of aging as a defect in stem cell regulation by the tissue microenvironment.
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Finally, we apply these ideas to understand the role of aging on breast cancer
susceptibility.
1.1 The use of animal models to identify the hallmarks
of aging
Aging is the result of an evolutionary trade-off. The antagonistic pleiotropy
hypothesis was first introduced by George C. Williams in 1957 (Williams,
1957). Pleiotropy defines the phenomenon that a single gene controls more
than one phenotype. Williams proposed that aging is caused by the
combined effect of many pleiotropic genes that had a beneficial effect on the
organism’s fitness to increase reproduction in early life but also had an
adverse effect in older age. Thus, an antagonistically pleiotropic gene can be
selected for if it has advantageous effects in early life despite having negative
effects in later life (Carter and Nguyen, 2011). It explains in part why
organisms are never able to reach biological perfection (perfect adaptive fit)
through natural selection as deleterious genes are still selected and
propagated.
The modern history of the use of animal models began with the research of
Clive McCay, a nutritionist in the 1930s. In the course of research on cancer,
his group discovered that severe calorie restriction resulted in a significant
increase in the lifespan of rats (McCay et al., 1935). Thirty years ago, a new
era in aging research was initiated following the isolation of the first strains
in Caenorhabditis elegans (C. elegans) with extended lifespan (Klass, 1983).
A range of other non-mammalian systems have been used such as yeast,
drosophila, ants, and fish (Conn, 2011). Domesticated species, such as dogs
and cats, represent interesting aging model systems. Although the average
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canine lifespan of 10-12 years discourages longevity studies, dogs
spontaneously develop many age-related phenotypes (Fast et al., 2013). As
in dogs, several age-associated phenotypes happen in felines. Lifespan studies
in this species are likewise problematic (Taylor et al., 1995); however, their
aging phenotype may make them attractive models.
We share more than 90% of our genome with the mouse (Mouse Genome
Consortium Sequencing, 2002) and the ease with which its genome can be
manipulated and analyzed, makes the mouse a convenient system to
translate knowledge from lower organism models into mammalian species.
Therefore, a number of mouse aging models have been generated. For
instance, the senescence accelerated mouse (SAM) strains of mice showed
different degree of loss of activity, hair loss and early death (Takeda, 1999).
A mouse model of ataxia telangiectasia (AT) was created by disrupting the
Atm gene. This AT phenotype is similar to the human AT phenotype which
has a wide variety of clinical manifestations including premature aging
(Barlow et al., 1996). In addition, other mutant models of mice have been
reported to have a significant increase in lifespan (reviewed in (Liang et al.,
2003)). The naked mole rat (NMR) is a non-genetically engineered model of
murine aging and is the longest-living rodent known to man, with a
maximum lifespan of approximately 30 years (Jarvis, 1981). NMRs aged over
24y do exhibit signs of aging consistent with human. However, rodents have
been separated from humans for more than eighty million years with distinct
evolutionary pressures. Many significant differences in processes implicated
in aging and immortalization exist between human cells and cells derived
from rodent model systems. For example, in contrast to human tissues, most
mouse tissues have active telomerase which may explain the high frequency
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of spontaneous immortalization in culture of mouse cells compared to human
(Prowse and Greider, 1995). Moreover, the roles of the cyclin-dependent
kinase inhibitors are drastically distinct in the two species: p16INK4a takes
center stage in senescence (described below) and tumor suppression in
human cells, whereas alternate reading frame protein (ARF) assumes a more
important role in mouse cells. In a comparable way, retinoblastoma protein
(pRb) suppresses p16INK4a expression in human but not mouse (Gil and
Peters, 2006). Thus, the mouse model might not be an ideal aging model
and a focus on longitudinal studies might be essential. Another species with
close evolutionary affinity and similarity (compared to rodents) are the
non-human primates. The human relevance of health diseases associated
with aging in primates is unparalleled. Transgenic primate models have now
been generated, and useful models for studying genetic pathways involved in
aging could therefore be modulated (Yang et al., 2008). However, their long
lives and complex social needs make primate aging research challenging and
expensive. Currently, primate research is conducted in only a small number
of laboratories.
As a model of aging, August Weismann suggested that multicellular
organisms become more fragile with age due to a mechanism that limits the
proliferative potential of the cells (Weismann, 1889). This cell condition has
been described in human fibroblasts in culture and is known as senescence
(Hayflick, 1965; Hayflick and Moorhead, 1961) which is the irreversible arrest
of cell proliferation. Cells become senescent following the detection of DNA
damage and the activation of persistent DNA damage response (DDR)
(d’Adda di Fagagna, 2008) and oncogenic stimuli. Telomeres at the end of
chromosomes shorten during mitosis, eventually become too short and are
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recognized as DNA damage, causing cells to become senescent (d’Adda di
Fagagna et al., 2003; Herbig et al., 2004). There is increasing evidence
regarding the importance of cellular senescence as prevention against cancer
(Serrano et al., 1997). This tumor suppressive mechanism contributes to
aging by reducing the regenerative capacity of tissues and by degrading
tissue structures, as senescent cells accumulate with age and secrete
inflammatory cytokines and tissue remodeling enzymes. For instance, the
pro-inflammatory cytokines interleukin (IL)-6 and IL-8 stimulate malignant
phenotypes (Campisi and d’Adda di Fagagna, 2007). Do senescent cells
reflect the aging process? Or do they contribute to the aging process and
age-related diseases? There are no definitive answers to these questions.
Recent work on human mammary epithelial cells (HMEC) cultured in vitro
revealed two distinct senescence barriers: stasis, resulting from chronic or
acute stress, and telomere dysfunction due to telomere attrition (Garbe
et al., 2009). Finite lifespan HMEC are also vulnerable to oncogene-induced
senescence (OIS). Some HMEC may cease growth as a consequence of
terminal differentiation. Thus, cellular senescence in culture might be
attributed to cell culture conditions and stress rather than aging per se.
Accumulated data support the notion that the loss of telomere repeats in
cells contributes to human aging (reviewed in (Aubert and Lansdorp, 2008)).
This notion is not widely accepted, primarily because the average telomere
length varies a lot between species and individuals of the same age.
Moreover, there were no associations between telomere length and age in
HMEC (Sputova et al., 2013). The accumulation of senescent cells in tissues
and organs with age might be attributed to an increased production of
various stimuli that induce senescence (Garinis et al., 2008). Alternatively,
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the elimination of senescent cells may decrease with age due to the alteration
of the immune system with aging (reviewed in (van Deursen, 2014)).
Simple model organism to higher level mammalian species models in aging
research permitted the recent categorization of nine hallmarks that
contribute to the aging process (reviewed in ((López-Otín et al., 2013)).
These hallmarks are: genomic instability, telomere attrition, epigenetic
alterations, loss of proteostasis, deregulated nutrient sensing, mitochondrial
dysfunction, cellular senescence, stem cell exhaustion, and altered
intercellular communication (Figure 1). Because stem cells regenerate adult
tissues and contribute to the development of cancer, age-related changes in
stem cells likely contribute to age-related diseases. Evidence is emerging
regarding hallmarks of aging at the stem cell level.
1.2 Stem cell and aging
In many tissues, homeostatic maintenance and regenerative responsiveness to
injury depend on tissue-specific stem cells: long-lived cells with the capacity
to both self-renew and differentiate to produce mature daughter cells. The
ability of tissue stem cells to balance quiescence with proliferation appears to
be critical for their survival and maintenance of appropriate physiological
and regenerative responses (reviewed in (Cheung and Rando, 2013)). Stem
cells in many tissues undergo profound changes with age, exhibiting dulled
responsiveness to tissue injury, misregulation of proliferative activities and
declining functional capacities (reviewed in (Signer and Morrison, 2013)).
These changes result into reduced effectiveness of cell and tissue regeneration
in aged organisms. In the quest for understanding their alteration with aging,
analysis of stem cells in diverse tissues showed the presence of the nine
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Figure 1: The nine hallmarks of aging. The scheme enumerates the
nine hallmarks of aging: genomic instability, telomere attrition, epigenetic
alterations, loss of proteostasis, deregulated nutrient sensing, mitochondrial
dysfunction, cellular senescence, stem cell exhaustion, and altered intercellular
communication. While these hallmarks are identified at the cellular level, a
light is shed on the hallmarks of aging at the stem cell level. From (López-Otín
et al., 2013).
hallmarks of aging (Figure 2). Pathways induced by reactive oxygen species
(ROS) which "leak" during mitochondrial activity, appear to contribute to
perturbed stem cell functions in the context of aging (Pervaiz et al., 2009;
Takubo et al., 2013; Yu et al., 2013). In addition, DDR pathway showed
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reduced activity in stem cells with age (Moskalev et al., 2013). Thus, the
accumulation of damage in the cells eventually reaches a threshold, resulting
in altered stem cell function in aged animals. Proteostasis (protein
homeostasis) has been implicated as an important factor of stem cell
maintenance through studies in hematopoietic stem cells (HSCs). Autophagy
is a lysosomal degradation pathway which prevents cellular damage.
Autophagy-related gene 7 (Atg7 ) is an essential autophagy gene and deletion
of Atg7 leads to an increase in ROS levels and reduces HSCs function,
although the overall Lin-Sca-1+cKit+ (LSK) compartment was expanded
(Mortensen et al., 2011). Moreover, autophagy induction by FoxO3A is an
essential mechanism that protects HSCs from metabolic stress during aging
(Warr et al., 2013). Another hallmark of aging implicates mitochondria
function in stem cells. Over-expression of peroxisome proliferator-activated
receptor gamma coactivator 1 (PGC-1) stimulates mitochondrial activity.
PGC-1 delays the age-dependent decline in intestinal stem cells in drosophila
and extends longevity in old flies (Rera et al., 2011), although its role in
mammalian stem cells needs further investigation.
Epigenetic regulation is important in determining stem cell function.
Alterations in the epigenome that occur with age can disturb cellular
functions in aged stem cells. Epigenetics include modifications of histone
proteins, RNA and DNA methylation. The most common form of DNA
methylation is the addition of a methyl group to the 5’ cytosine of C-G
dinucleotides, denoted CpGs. Epigenetic clock defines DNA methylation
levels at specific sites in the genome that are correlated with age (Horvath
et al., 2012). Epigenetic clock sites show a relationship between age and
DNA methylation that is consistent between individuals (Hannum et al.,
2013). For instance, aging HSCs show increases in DNA methylation in the
21
Figure 2: The aged stem cell. The cartoon shows the common pathways
contributing to stem cell loss and dysfunction in the aging process. The nine
hallmarks of aging have been identified at the stem cell level. From (Oh et al.,
2014).
regions of the genome important for lineage-specific gene expression
(Beerman et al., 2013). Cellular senescence is another hallmark of stem cell
aging as HSCs from older donors exhibit increased senescence (Stenderup,
2003). Moreover, depletion of p16INK4a expressing cells in mice extended
their life-span and attenuated age-related diseases (Baker et al., 2016). Thus,
in some cases these aging-associated phenotypes can be reversed to restore
the regenerative function of stem cells (reviewed in (Oh et al., 2014)). As one
of the hallmarks of aging, stem cell exhaustion may also be driven by an
imbalance of stem cell quiescence and proliferation. It is crucial to maintain
this balance to preserve the stem cell pool through multiple rounds of tissue
regeneration (Mansilla et al., 2011).
22
Conversely, a functional decline is not necessarily caused by a loss of the
ability to self-renew but may also reflect an inability of stem cell progeny to
properly differentiate, resulting in the accumulation of non-fully
differentiated cells and an increased potential for oncogenic transformation.
Elevated Jun N-terminal kinase (JNK) activity in intestinal stem cells causes
a misregulation of cell differentiation leading to a stem cell pool
accumulation (Biteau et al., 2008). In addition, cells from the
gastrointestinal tract from older mice exhibit reduced regenerative potential
despite an increase in the number of crypt cells (Martin et al., 1998). In
addition, high levels of the inflammatory cytokine Rantes are found in the
aging stem cell milieu, resulting in a decrease in T-cell progeny concomitant
with an increase in myeloid progenitors (Ergen et al., 2012). As a
comparison, the number of HSCs in the bone marrow increases with age
(Beerman et al., 2010, 2013; Challen et al., 2010) with no difference in
cycling activity and aging skews differentiation potential toward myeloid
lineages (Geiger et al., 2013). Astroglial neural stem cells (NSCs) in the
sub-ventricular zone (SVZ) give rise to transit-amplifying progenitors. A
progressive age-related cognitive impairment has been observed in different
species. This is correlated with decay in the number of NSCs and
accumulation of transit-amplifying progenitors (Encinas et al., 2011; Lugert
et al., 2010). These changes correlate with a discrepancy to produce newborn
neurons in the aged brain.
Intuitively, increased stem cells may seem beneficial. However, this
accumulating pool of stem cells is functionally impaired and may be more
susceptible to oncogenic events. In conclusions, tissue stem cells progressively
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experience cell-intrinsic alterations that profoundly affect their regenerative
function with aging. In addition, extrinsic age-related alterations in the
microenvironment are attributed to tissue homeostasis disruption. Stem cells
reside in specialized microenvironments, called niches that promote their
maintenance and regulate their functions. Aging of niche cells and
age-dependent alterations in the components of stem cell niches can cause
damaging changes in stem cell function.
1.3 The stem cell niche
Stem cells reside in a specific location within the tissue (for review see (Fuchs
et al., 2004)). To mention but a few examples, bone marrow serves as the
pioneer system for studying stem cells. Homing experiments pointed the
HSC niche to the endosteal surface of the bone marrow (Nilsson et al., 2001).
In the skin, the epithelial stem cell niche is located in the bulge area of the
hair follicle (Cotsarelis et al., 1990; Niemann and Watt, 2002). The intestinal
stem cells are proposed to be located at the fourth or fifth position from the
crypt bottom, above the Paneth cells (Barker et al., 2007). Neural stem cells
reside in the SVZ of the adult mammalian brain (Qian et al., 1998). In the
muscle, skeletal satellite cells are positioned between the basal lamina and
the plasma membrane of muscle fibers (Muir et al., 1965). In mice, the
location of mammary gland stem cells is not well defined, but was narrowed
down to the peripheral cap cells of the terminal end buds (reviewed in
(Woodward et al., 2005)). However, a human breast epithelial stem cell zone
in vivo and a progenitor hierarchy both inside and outside this zone have
been identified (Villadsen et al., 2007).
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A microenvironment is defined by the sum of cell-cell, extracellular matrix
(ECM), and cell-soluble factor interactions, in addition to its architecture
and physical constraints that are experienced by a cell. There is increasing
evidence that the microenvironment regulates stem cell and progenitor fate.
For instance, progenitors in skin and skeletal muscle can exhibit homing to
vacated stem cell niches and reacquire stem cell traits (Collins et al., 2005;
Nishimura et al., 2002; Sacco et al., 2008). Mimetic combinatorial
microenvironments reveal a quantification of adult stem and progenitor cell
fate decisions (LaBarge et al., 2009; Soen et al., 2006). Moreover, previous
work showed that stem cell niche microenvironments regulate stem cell
functions (LaBarge et al., 2007). The ECM provides support to the tissue in
addition to regulate its homeostasis via different mechanisms (Figure 3).
Anchorage to the basement membrane is essential for diverse biological
processes, including asymmetric cell division, quiescence and maintenance of
tissue polarity. Certain ECM components can selectively bind to different
growth factors and function as a signal co-receptor and modulate the
direction of cell-cell communication (Lu et al., 2011). The ECM also
modulates signals to the cell by using its fragment processed by proteases,
such as matrix metalloproteinases (MMPs). Finally, cells sense the
biomechanical properties of the ECM, including its stiffness via cell
mechanics, and change a wide variety of mechanoresponses accordingly.
Therefore, stem cell fate and homeostasis are modulated by a combination of
different microenvironment cues.
In order to understand this process, a deconstruction of each component of
the niche is crucial to recapitulate their specific role. Specifically, increasing
evidence support the role of ECM stiffness as a rheostat for stem cell and
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Figure 3: Mechanisms of ECM function. The various functions of the
ECM are: 1) anchorage to the basement membrane, 2 and 3) regulation
of cell migration, 4) sink of growth factor signaling molecules, 5) signal co-
receptor or 6) presenter, 7) regulation of functional fragments via matrix
metalloproteinases (MMP), and 8) mechanosignaling. From (Lu et al., 2012).
tissue homeostasis. The stiffness or elastic modulus measures an object or
substance’s resistance to being deformed elastically when a force is applied to
it. Each organ has a distinct rigidity pattern, governed by the ECM stiffness
and the three-dimensional architecture of the tissue. The stiffness of a
mammary gland is around 160 Pascal (Pa), while muscle stiffness is 10kPa
and collagenous bone stiffness is 100kPa (Reviewed in (Levental et al.,
2007)). As a comparison, regular tissue culture dish stiffness is between 2
and 4GPa (Callister and Rethwisch, 2000). Studies of mesenchymal stem cell
(MSC) differentiation highlighted the importance of how cells respond to
different stiffness. MSC differentiate into osteoblasts when cultured on stiff
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substrata, into myoblasts when grown on intermediate stiffness substrata or
into neurons and adipocytes when cultured on a soft ECM (Figure 4) (Engler
et al., 2006).
Figure 4: Influence of mechanical and physical properties of the
ECM on cell behavior. By recapitulating different ECM elasticities in
vitro, it was found that MSC differentiate optimally into neurons, adipocytes,
skeletal muscle cells or osteoblasts at elasticities that match the physiological
ECM stiffness of their corresponding natural niche. From (Halder et al.,
2012).
Cell mechanics involves three steps (Figure 5). Mechanosensing at the
molecular scale requires the ability to pull against the matrix. Sensing
matrix elasticity occurs through cell-cell and ECM interactions mediated by
adherens, integrins, vinculin, focal adhesion kinase (FAK), and others
(Beningo et al., 2001; Bershadsky et al., 2003; Tamada et al., 2004). The
actinomyosin network includes RhoA, which regulates the actin cytoskeleton
in the formation of stress fibers (SF) and focal adhesions (FA). Activation of
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ROCK1/ROCK2 causes increased activity of the motor protein myosin II by
phosphorylation of the myosin light chain (MLC) and inactivation of the
MLC phosphatase (Ishizaki et al., 1997; Kimura et al., 1996). Vinculin and
talin are part of a FA complex-based mechanosensing mechanism and are
capable of unfolding under physiological force. Talin binds to integrins and
actin, upon unfolding, expose domains for vinculin which has itself a
force-dependent activation (Golji et al., 2011). Mechanosensing through
stretch activated channels (SAC) are reviewed in (Holle and Engler, 2011).
In addition, the contractile forces exerted by filamentous actin (F-actin)
cables and their associated myosin motors are responsible for generating
tension in cells (Schwartz, 2010; Vogel and Sheetz, 2006). Next,
Figure 5: Cell mechanics. Cell Mechanics involves three steps:
mechanosensing, mechanotransduction and mechanoresponse. Adapted from
(Bischofs and Schwarz, 2003; Vogel and Sheetz, 2006).
mechanotransduction signals relay the sensing cues to the nucleus. The
Hippo pathway was originally identified as the signaling that control organ
size in drosophila. The pathway takes its name from the main signaling
components Hippo (Hpo). Mutations in this gene lead to tissue overgrowth,
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or a “hippopotamus”-like phenotype (Wu et al., 2003). The transcription
co-activators Yes-associated protein (YAP) and transcriptional co-activator
with PDZ-binding motif (TAZ also known as WWTR1) belong to the Hippo
pathway, and recently emerged as key mediators of mechanotransduction.
Upon activation of the Hippo pathway, mammalian Ste20-like kinases (MST1
and MST2) phosphorylate and activate large tumor suppressor kinases
(LATS1 and LATS2) which in turn phosphorylate YAP and TAZ (Kanai
et al., 2000; Sudol, 1994). Phosphorylated YAP and TAZ are excluded from
the nucleus and accumulate in the cytoplasm where they are degraded by the
proteasome. When the Hippo pathway is inactivated, YAP and TAZ are
dephosphorylated, translocate into the nucleus and regulate gene
transcription when associated with DNA-binding transcription factors such
as TEA domain family members (TEAD) (Figure 6) (Pobbati and Hong,
2013; Zhang et al., 2009; Zhao et al., 2008). In addition, angiomotin
(AMOT) family proteins interact with YAP and TAZ at the tight junctions
to promote their phosphorylation by the Hippo pathway (Zhao et al., 2011).
YAP and TAZ are tightly linked to the actomyosin cytoskeleton, thus they
not only respond to mechanical cues, but are also mediators of mechanical
signals (reviewed in (Halder et al., 2012)). YAP and TAZ are the main
triggers of various cell- and context- dependent mechanoresponses. Paired
with TEADs, they upregulate the expression of several growth promoting
factors. The direct targets are connective tissue growth factor (CTGF),
ankryn repeat domain 1 (ANKRD1) and cystein-rich angiogenic inducer 61
(Cyr61) (Zhao et al., 2008), in addition to Ki67, Axl (Kim et al., 2013; Xu
et al., 2011), c-Myc and survivin (Dong et al., 2007). CTGF has been shown
to induce collagen I expression in human fibroblasts (Lin et al., 2013) which
is an important ECM component. The Hippo pathway is involved in tissue
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Figure 6: A model of Hippo pathway regulation. Phosphorylated
MST1/2 phosphorylate LATS1/2 which in turn phosphorylate YAP/TAZ
which are excluded from the nucleus. Nuclear YAP/TAZ associate with
TEADs to activate target gene transcription. AMOT regulates YAP/TAZ
localization via physical interaction and promoting YAP/TAZ phosphorylation
by the Hippo pathway. From (Zhao et al., 2011).
specific stem cells, tissue homeostasis (reviewed in (Kodaka and Hata, 2015)),
tissue growth control (Zhao et al., 2007) and cancer (reviewed in (Harvey
et al., 2013)).
In conclusion, the stem cell niche has a specific location within a tissue and
is defined by its physical constituents in addition to its molecular
components and architecture. Thus, niche alteration is of critical concern.
Cancer may result from errant stem or progenitor cells that were misguided
by their microenvironment (Bissell and Labarge, 2005). Given the
relationship between reduced stem cell activity, loss of tissue homeostasis,
and aging, questions emerge. Is loss of tissue homeostasis due to an inability
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of stem cells to respond appropriately to signals from the niche or reduced
signaling from the niche?
1.4 Effect of aging on niche microenvironment and
stem cells
Aging of the niche and its components can cause alteration in stem cell
function. The number of cap cells in the testes and hub cells in the ovaries,
which serve as support for germline stem cells (GSCs), decreases with age in
drosophila. This causes an alteration of the bone morphogenetic protein
(BMP) signaling from the niche that is necessary for GSC maintenance
(Boyle et al., 2007; Pan et al., 2007). Similarly, expression of glial cell-derived
neurotrophic factor, which is required for normal regulation of
spermatogonial stem cell self-renewal and differentiation, is reduced with age
in Sertoli cells, the nurse cells of the testes (Ryu et al., 2006). Both systemic
and local factors contribute to lineage skewedness of HSCs. Rante/Ccl5
cytokine has been shown to increase myeloid progenitor proliferation , and is
highly expressed in the aged stem cell milieu (Ergen et al., 2012). Muscle
fibers are an important source of ECM signals to regulate stem cell function.
Increased levels of FGF signaling in the aged satellite cell niche lead to the
loss of quiescence and depletion of the resident stem cell population, which
eventually diminishes muscle regenerative capacity (Chakkalakal et al., 2012).
A loss of Notch signaling induces a decline in skeletal muscle stem cell
activity resulting in impaired regeneration of aged muscle (Conboy et al.,
2003; Conboy and Rando, 2002). In addition to local signals, aging also
causes changes in systemic factors that can impact tissue stem cells. This is
the last hallmark of aging listed above. The exposure of satellite cells from
old mice to young serum increased Notch activation and restored the
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proliferation and regenerative capacity of aged satellite cells (Conboy et al.,
2005), illustrating the role of systemic environment on stem cell function. In
addition, whole-muscle transplantation between old and young rats resulted
in a significant muscle regeneration only in young hosts (Carlson and
Faulkner, 1989). Another group rejuvenated muscle stem cells by culturing
them on hydrogels restoring strength to injured muscles from aged mice
(Cosgrove et al., 2014), illustrating the predominant role of
microenvironment stiffness.
The status of the ECM affects mechanotransduction, which regulates
mechanical stress, cell shape, architecture and signaling. With aging, a
persistent inflammatory response increases fibrosis, leading to altered
composition of the tissue and increased rigidity. In the muscle, the normally
laminin-rich myofiber niche shifts toward a composition enhanced in collagen
IV (Kovanen et al., 1988). Moreover, old wild-type myoblasts continue to
produce collagen III but cease to synthesize collagen I (Alexakis et al., 2007).
Both cellular fibroblast aging and defective mechanical stimulation in the
aged tissue contribute to reduced collagen synthesis (Qin et al., 2014; Shuster
et al., 1975; Varani et al., 2006). On another hand, enhanced collagen
cross-linking, mediated by lysyl oxidase, promotes growth and invasion by
pre-malignant human mammary epithelial cells. In addition, interactions
between adhesion molecules such as filamin A and b1 integrin can alter the
cells’ response to collagen tension (Gehler et al., 2009; Levental et al., 2009).
Increased stiffness also can induce adipocyte progenitors to differentiate into
fibroblasts, which can positively feedback to further increase tissue stiffness
(Chandler et al., 2012). YAP/TAZ produce Laminin511 via a feedback loop
involving activation of integrins which feedback on YAP/TAZ to contribute
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to breast cancer progression (Chang et al., 2015). This correlates well with
previous work showing that YAP/TAZ activity is increased in aggressive
human mammary tumors in regions of higher collagen cross-linking (Acerbi
et al., 2015). This might have implications for tumor treatment, since ECM
stiffness promotes, through YAP/TAZ, the resistance of HER2-amplified
breast cancer cells to HER2-targeted kinase inhibitor lapatinib.
Down-regulation of YAP/TAZ eliminated modulus-dependent lapatinib
resistance (Lin et al., 2015).
Little is known about whether YAP/TAZ play a role in phenotypes of aging.
Deficiency in C. elegans YAP resulted in overall healthier aging relative to
controls (Iwasa et al., 2013). TAZ functions as a rheostat that modulates
MSC differentiation by promoting osteoblast while simultaneously preventing
adipocyte differentiation (Hong et al., 2005). During aging, the progressive
loss of bone mass occurs with a gradual replacement of the bone marrow
with fat (Moerman et al., 2004). Both of these phenomena could be
explained by a reduction in TAZ-driven gene expression with age. Thus,
mechanical regulation of stem cell homeostasis via the Hippo pathway
maintains an equilibrium between altered differentiation and proliferation.
Altogether, emerging evidence suggests the presence of the nine hallmarks of
aging at the stem cell level and that dysregulation of stem cell activity is an
important determinant of aging phenotypes. In addition to its molecular
constituents, the physical constraints of the niche tightly regulate stem cell
homeostasis. The stem cell intrinsic- and extrinsic- alterations are the main
causes of aging. Thus, we define the microenvironment alteration of stem cell
regulation as a previously unappreciated hallmark of aging. To understand
the aging process in human, each component of the niche is required to be
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identified in order to characterize specific microenvironment functions in
stem cell regulation in the context of aging. Although an extensive range of
animal models have been developed to study aging, these models do not
entirely recapitulate the human model.
1.5 Human models to study aging
The laws, morals, and ethics of modern society ensures the protection of
human subjects. Thus, no research as extended as experiments performed on
rodent models can be conducted on humans. Longitudinal studies follow
individuals throughout their lives while cross-sectional studies compare
young and old individuals at distinct time points (Cevenini et al., 2015).
Both types of studies are observational, not mechanistic. However in order to
study aging at the cellular level, human tissue can be obtained. Fluids and
blood are easily collected (Lifshitz and Kramer, 2000; Navasesh, 1993; Tuck
et al., 2009), in addition to tissue from patient’s tumor (Mitra et al., 2013),
biopsies, organ donation (Millar et al., 2007), and surgery. The human blood
has been extensively studied in patients of all age-groups. With age, there is
evidence of a gradual decline in all of the hematopoietic system functions
(Carmel, 2001; Gomez et al., 2005). Cell lines are grown from tumors and
biopsies, and are used in experimental investigation of cancer but genomic
differences between cancer cell lines and tissue samples have been pointed
out (Ertel et al., 2006; Gillet et al., 2011; Stein et al., 2004). An illustrating
example is the MDA-MB-435 strain, derived from a metastatic breast tumor.
It is debated whether the cell line has a breast or a melanoma cell line
identity (Ellison et al., 2002; Lacroix, 2009). Nevertheless, important work
with primary tumors in the context of aging revealed that breast tumors
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have age-specific gene expression signatures (Yau et al., 2007).
Moreover, age-related changes in epigenetic modifications, such as DNA
methylation, have been reported in a number of different tumors (Issa et al.,
1994). Aging has also been studied on various sources of human tissue. To
cite but a few: epithelial skin tissue (Swindell et al., 2012; Varani et al.,
2006), epidermal keratinocytes (Berdyyeva et al., 2005), breast tissue (Garbe
et al., 2012; Stampfer et al., 2013), sub-cutaneous adipose tissue (Bolinder
et al., 1983), kidney (Melk et al., 2005), ex vivo lungs (Thurlbeck, 1975).
However, cell lines derived from organs are mainly cultured on tissue culture
dishes, with formulated media that does not resemble their natural habitat.
Efforts have been made to develop organ culture as an advancement of tissue
culture methods of research. For example, scientists reported a successful
trial of bladders grown in vitro and given to humans (Atala et al., 2006). A
jawbone has been grown from stem cells (Grayson et al., 2010), a lung has
been engineered (Petersen et al., 2010) and renal tubules have been cultured
(Tumlin et al., 2008). Silk cut from silkworm cocoons has been successfully
used as growth scaffolding for heart tissue production (Patra et al., 2012).
However, organ cultures suffer from important limitations: results from
organ cultures are often not comparable to those from whole animal studies.
For each study, fresh organ cultures have to be initiated, which makes them
labor-intensive and they can be maintained only for a few months.
Samples and tissue can be obtained from human, and efforts have been made
to retain the in vivo characteristics of these tissues in vitro. Human models
can be successfully used to study normal aging and age-related pathologies.
As cancer is the main age-related disease and more than 80% of women
diagnosed with breast cancer are over 50 years old, we review in this final
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chapter the use of human mammary epithelial cells as a model to study
aging and the susceptibility to breast cancer.
1.6 Breast cancer as a model of aging disease
Mammary cells present a convenient model system because large quantities of
normal and abnormal tissues are available due to the frequency of reduction
mammoplasty and mastectomy surgeries. Aging is the greatest risk factor
for breast cancer. Aging has been attributed to degenerative changes in
mammary stem cells and microenvironment that regulates stem cell activity.
In order to understand the microenvironment regulation of mammary stem
cells and its alteration with age, it is crucial to deconstruct each property of
the niche and assess its role in mammary stem cell quiescence and fate as a
function of age. First, we outline the human mammary gland hierarchy and
aging biology. We observe that the luminal lineage is the principal subtype of
post-menopausal breast cancer. Then, we describe the principal breast cancer
treatments undergone by older women in order to emphasize the necessity to
find preventive cures. Finally, we report the recent advances in understanding
the microenvironment regulation of mammary progenitors and its alteration
with age.
1.6.1 Defining the mammary gland
Each breast is composed of up to 20 compartments called lobes. Each lobe is
made up of smaller lobules, where milk is produced. Lobes and lobules are
connected by a system of ducts that carry milk to the nipple (Figure 7). The
mammary gland is a hormone sensitive, branching, and bilayered tissue
consisting of an inner secretory luminal epithelial (LEP) layer, and an outer
contractile myoepithelial (MEP) layer surrounded by a basement membrane
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Figure 7: Schematic representations of the human and mouse
mammary glands. Muscles lie under each breast and cover the ribs. Each
lobe is composed of lobules which produce the milk carried through the ducts
and ultimately to the nipple. The mammary gland is surrounded by adipose
and connective tissue. In contrast, the mouse mammary epithelial tree does
not possess TDLUs, but comprises alveolar buds that are formed during each
estrous cycle. From (Visvader, 2009).
in a stromal connective tissue (Figure 8). The arbor-like gland is organized
into lobular acini that are interconnected by a system of ducts; the basic
functional units of the breast are termed terminal ductal lobular units
(TDLUs), which are derived from stem cells that reside in the ducts. TDLUs
are composed of an inner layer of cytokeratin (K)8-, K7- and K19-expressing
luminal epithelial cells (LEP; K14-/K5/6-/K19+/K8+/K7+) and an outer
layer of K14- and K5/6- expressing myoepithelial cells (MEP;
K14+/K5/6+/K19-/K8-/K7- (Figure 9)). Mammary progenitor cells express
K14 and K19 (Villadsen et al., 2007). Additionally, the receptor tyrosine
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Figure 8: The terminal duct lobular unit. A tissue section from a normal
mammary gland immunostained to show expression of the MEP and LEP
markers K14 (red) and K19 (green), respectively. A co-expression of K14 and
K19 in the central duct indicates the presence of progenitors. From Mark
LaBarge.
kinase cKit (CD117) was postulated to be a marker of luminal progenitors in
human (Lim et al., 2009; Regan et al., 2012). Previous work showed that
they were capable of multilineage differentiation (Garbe et al., 2012).
The Hippo pathway acts as a differentiation rheostat in the normal breast.
YAP expression is higher in the myoepithelium and myoepithelial cells have
a stronger nuclear YAP localization pattern (Jaramillo-Rodríguez et al.,
2014; Vlug et al., 2013). In addition, TAZ associates with SWI/SNF
chromatin-remodeling complexes to both repress the expression of luminal
specific genes and activate basal differentiation genes (Skibinski et al., 2014).
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Figure 9: Luminal and myoepithelial populations express lineage-
specific markers. (A) A tissue section from a normal mammary gland
immunostained to show expression of the MEP and LEP markers K14 (red)
and K19 (green), respectively. (B) Flow cytometry analysis of a HMEC
strain: MEP, is defined here as CD227-/CD10+, and LEP, is defined as
CD227+/ CD10-. Immunofluorescence of sorted cells for MEP and LEP
markers K14 (red) and K19 (green), respectively, verified that CD227+ LEP
were K14-/K19+, and CD10+ MEP were K14+/K19-. From (Chanson et al.,
2011).
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1.6.2 Axl may represent a breast stem cell marker
Axl is a member of the TAM (Tyro/Axl/Mer) receptor tyrosine kinase
family, united by a common protein ligand, Gas6, and extracellular domain
similarity to cell adhesion proteins (Linger et al., 2008) (Figure 10).
The Axl receptor tyrosine kinase has been closely associated with a wide
variety of advanced solid and myeloid cancers, and correlated with metastasis
and poor overall survival (Gjerdrum et al., 2010; Linger et al., 2008). Axl is
expressed by aggressive basal breast cancer subtypes that exhibit
mesenchymal and stem cell gene expression profiles (Blick et al., 2010; Neve
et al., 2006). Axl expression is induced by Epithelial to Mesenchymal
transition (EMT) transcription factors and Axl signaling is essential for
breast cancer metastasis in experimental systems (Gjerdrum et al., 2010).
Notably, Axl is distinguished from other EMT-related genes as its expression
is enhanced in matched breast cancer patient metastases relative to the
primary tumor (Gjerdrum et al., 2010). These results indicate that Axl
expression may be associated with epithelial plasticity that drives both
malignant progression and metastatic colonization.
Axl is a common effector of the EMT and regulates the expression of EMT
markers, such as E- and N-cadherin, Snail and Slug (Asiedu et al., 2014).
Recent evidence highlights a role for Axl signaling in the maintenance of
progenitor cell types. Axl was detected in neuronal progenitor cells (NPC) in
the subventricular zone of the brain; and inhibition of Axl or Gas6 in NPC
induced neuronal differentiation consistent with a role for Gas6-Axl signaling
in neuronal progenitor maintenance (Gely-Pernot et al., 2012; Wang et al.,
2011). Axl was reported to be expressed by CD34+ hematopoietic precursors
and Axl inhibition was associated with impaired natural killer (NK) cell
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differentiation due to reduced precursor cell pools (Caraux et al., 2006).
Indeed, Axl activation was necessary for cKit activity in NK precursors
(Park et al., 2009). Remarkably, recent studies show that Axl transcripts are
associated with a gene signature derived from pluripotent human embryonic
germ cells that includes SOX9 and that the inhibition of Axl kinase activity
facilitates induced-pluripotent stem cell (iPSC) generation by suppressing
EMT (Pashai et al., 2012; Son et al., 2013). Hence, it is plausible that Axl
signaling may contribute to stem/progenitor plasticity in other tissues.
Figure 10: Axl and Gas6 structure. The intracellular kinase domain
includes the seven-residue sequence conserved among TAM family receptor
tyrosine kinases. Proteolytic cleavage of residues between the transmembrane
and closest FNIII domains renders a soluble isoform of Axl, which contains
its fully functioning extracellular domains. Gas6 is activated by vitamin
K-dependent carboxylation of the Gla domain. From Atlas of Genetics and
Cytogenetics in Oncology and Haematology website.
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Gas6 requires γ-carboxylation of the N-terminal γ-carboxyglutamic acid
(Gla) domain to activate Axl (Hasanbasic et al., 2005; Nakano et al., 1997;
Tanabe et al., 1997). This is carried out in the endoplasmic reticulum (ER)
by the vitamin K dependent carboxylase complex (VDCC). The
carboxylation reaction is strongly dependent vitamin K levels, which are
determined by the vitamin K recycling enzyme complex. Vitamin K
2,3-epoxide reductase complex subunit 1 (VKORC1) is the target of warfarin.
Decarboxylated Gas6 is suspected to be an Axl antagonist. Gas6 has very
high affinity for Axl (0.4nM); and decarboxylated Gas6 is reported to have a
binding affinity of 4nM (Nakano et al., 1997). Hence regulation of
γ-carboxylation activity will toggle Gas6 between activator and inhibitor
states. Mammary luminal epithelial cells express Gas6 and the ER
carboxylase complex, and secrete Gas6 (Ji et al., 2011). Hence when luminal
cells secrete carboxylated Gas6, they will activate Axl and maintain the
juxtaposed suprabasal progenitors in the multipotent state. If the luminal
cells inactivate the γ-carboxylase activity, they would secrete an Axl
inhibiting decarboxyated Gas6. This would block Axl signaling and drive the
progenitors into luminal commitment. This hypothetical mechanism would
contribute to the maintenance of luminal epithelial homeostasis.
1.6.3 Normal mammary gland changes with aging
Normal breast tissue aging is associated with involution of the breast and a
loss of mammographic density (Figure 11) (Hutson et al., 1985; Maskarinec
et al., 2006). Mammographic density is a major risk factor for a breast
cancer subtype (Bertrand et al., 2013; Maskarinec et al., 2006) (Figure 11);
however, the significance of that tissue density has been poorly understood.
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Matrix stiffness is mechanistically important in breast cancer progression;
rigid breast tissue correlates with high breast cancer risk and drives
malignant phenotypes in breast cancer cell lines (Paszek et al., 2005; Yu
et al., 2011). However, radiographic density of breast tissue decreases with
age, suggesting that the mechanical environment is also altered (Benz, 2008).
Over time, the collagenous stroma and glandular elements are replaced by
fatty tissue. The decline of mammographic density with age parallels that of
the rate of breast tissue aging in a model proposed by Pike (Boyd et al., 2005;
McCormack et al., 2010). Although the mammographic density decreases, we
do not know whether the mammary gland itself may become tenser with age.
Figure 11: Albeit mammographic density is a breast cancer risk, it
decreases with age. Left, the fibroglandular tissue has a higher X-ray
attenuation coefficient than the fat tissue, and therefore appear brighter on
the radiograph. The upper breast has a higher mammographic density than
the lower breast. Right, unadjusted mean percent mammographic density as
a function of age group and case status. Adapted from (Maskarinec et al.,
2006).
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Changes in endocrine regulation and in the cellular and molecular
composition of breast microenvironment are the most important factors that
a majority of women aged over 50y have in common. Estrogen and
progesterone can directly impact the epithelium by causing fluctuations in
the stem cell pool (Asselin-Labat et al., 2010; Hilton et al., 2014). The
effects of cyclic and prolonged exposures of the normal epithelium to sex
hormones over a lifespan are not well defined, although it is known that an
increase in sex hormones are associated with a higher breast cancer risk
(Endogenous Hormones Breast Cancer Collaborative Group, 2003). Aging is
also associated with changes in protease expression (Well et al., 2007), that
could be related to age-related discontinuities in laminin-111 of the basement
membrane (Howeedy et al., 1990), which could impact tissue polarity
(Gudjonsson et al., 2002). These changes occur gradually, thus slowly
evolving the molecular constituency of the breast microenvironment.
1.6.4 Post-menopausal breast cancer
Despite the fact that breast cancer incidence increases with the age of the
patient, it is generally stated that old women develop cancer with a relatively
slower growth (Clark, 1992; Eppenberger-Castori et al., 2002; Peer et al.,
1993; Schaefer et al., 1984) and that their prognosis is therefore better than
the one of the general population (Bonnier et al., 1995; Schaefer et al., 1984).
Advanced age is associated with favorable biological features, including a
higher proportion of estrogen receptor (ER)-positive cases (Anderson et al.,
2001; Clark et al., 1993; Diab et al., 2000). Gene expression is used to
classify invasive breast cancers into biologically and clinically distinct
subtypes that are known as Luminal A, Luminal B, HER2-Enriched
44
(HER2-E) and Basal-like (Prat and Perou, 2011; Sørlie et al., 2001). The
incidence of luminal tumors (luminal A and luminal B combined) increases
with age, whereas the incidence of basal-like tumors decreases (Jenkins et al.,
2014). The luminal A subtype has a better outcome than the other subtypes.
Nevertheless, a significant proportion of patients older than 70y and of the
40–50y subgroups will develop large, highly proliferating, high histological
grade, ER-positive luminal B tumors that are associated with positive nodal
invasion (Durbecq et al., 2008). Moreover, even if the age-related hormone
positive breast cancers are less aggressive, they are more insidious and the
risk of recurrence in age-related breast cancers is protracted (Esserman et al.,
2011).
Age-related changes in epigenetic modifications, such as DNA methylation,
have been reported in a number of different tumors (Issa et al., 1994; Waki
et al., 2003). An age-dependent, estrogen receptor-independent gene
expression signature identified in type-matched breast tumors (Yau et al.,
2007), also suggests epigenetic changes are involved in the pathogenesis of
age-related breast cancers. Thus, the biology of post-menopausal breast
cancer may differ substantially from that of younger women, suggesting the
role of aging in its susceptibility. In addition, older women, may be offered
different or no treatments for breast cancer leading to higher mortality.
1.6.5 Treatments of post-menopausal breast cancer
Older women with breast cancer are less likely to be offered or receive
standard treatments and that such under-treatment may impact on
disease-specific mortality (Bouchardy et al., 2007; Lavelle et al., 2007).
Better understanding treatment decisions of older women is important
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because less-aggressive treatment has been associated with greater breast
cancer mortality (Schonberg et al., 2010). Available treatments for
post-menopausal breast cancer patients and their associated risks are listed
in Table 2.
In conclusion, older patients should be treated according to tumor biology
Treatment Age-associated co-morbidity References
Surgery
(Mastectomy)
Morbidity and mortality in
anesthesia
(Turrentine et al., 2006;
Wyld and Reed, 2007)
Adjuvant
radiotherapy





Decline in bone mineral density (Mustacchi et al., 2007; Reid
et al., 2008)
Chemotherapy Toxicity and cardiac failure (Muss et al., 2005; Pinder
et al., 2007)
Trastuzumab Cardiac dysfunction (Chavez-MacGregor et al.,
2013; Tsai et al., 2014)
Table 2: This table summarizes the available treatments offered to women with
post-menopausal breast cancer. The age-associated co-morbidities impact the
treatment decision.
as for younger patients, except when co-morbidities or frailty are likely to
affect the benefits of treatment to a certain extend.
While breast cancer treatments exist for older women, the best solution
would be ultimately to find non-invasive means to prevent breast cancer. In
order to prevent age-related breast cancer, we need to understand the risks
associated with normal aging. Understanding what is an abnormal biological
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process, assumes knowledge of what is normal, for comparison.
Understanding the mechanisms by which a normal human epithelial cell
transforms to malignancy requires knowing the state of the starting point,
the normal human epithelial cell.
1.6.6 Understanding the breast aging process at the cellular level
Early passage HMEC cultures may be provided from an existing bank of
specimens (hmec.lbl.gov) (see Methodological Considerations).
Analysis of HMEC with age revealed that proportion of LEP increases while
proportion of MEP decreases with age. In addition, cKit progenitors which
are luminal progenitors and main suspect in the breast tumorigenesis are
also increasing in proportion with age (Figure 12) (Garbe et al., 2012).
These luminal cells express K14 and integrinα6 which are almost exclusively
Figure 12: Epithelial lineages change as a function of age. The
proportion of LEP and cKit progenitors increases while proportion of tumor-
suppressive MEP decreases with age. Adapted from (Garbe et al., 2012).
expressed in young myoepithelial cells. Thus, with age, cKit progenitors
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accumulate and give rise to incompletely differentiated luminal cells that
together appear to increase the potential for malignant transformation.
Accumulating evidence has provided support for the cancer initiating cell
hypothesis. A mechanistic insight can be drawn from breast cancer 1
(BRCA1) basal-like breast cancer. Heterozygous germ-line mutations in the
BRCA1 gene predispose women to breast and ovarian cancer with a lifetime
risk of breast cancer of up to 85% (Narod and Foulkes, 2004). Loss of
BRCA1 function results in blocked epithelial differentiation with expansion
of the undifferentiated stem/progenitor cell compartment (Liu et al., 2008).
In BRCA1-associated preneoplastic tissue and tumors, cKit was more highly
expressed (Lim et al., 2009). In addition, cKit over-expression prevents
normal differentiation (Regan et al., 2012) suggesting a role for cKit in the
BRCA1 mutated tumorigenesis. Instead of mutation, other mechanisms lead
to decreased BRCA1 expression (Turner et al., 2007) and increased
methylation (Esteller et al., 2000). Recent work demonstrated that in both
mice and humans, aging results in an increased incidence of double-stranded
breaks (DSB) in oocytes and a concomitant decrease in expression of DNA
repair genes involved in DSB repair, including BRCA1 (Titus et al., 2013).
Thus, applying the idea of the BRCA1-mediated expansion of progenitor
model, we hypothesized that during the normal aging process, cKit
progenitors become less responsive to their surrounding microenvironment
leading to their accumulation, dysfunction and susceptibility to
tumorigenesis.
The significant age-dependent changes to the mammary epithelium that we
observed could make older women more vulnerable to malignant progression
and underlay the increased luminal breast cancer incidence in women >55
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years. Myoepithelial cells are thought to be tumor-suppressive (Gudjonsson
et al., 2002) and progenitors are putative etiologic roots of some breast
cancers. Thus, during the aging process, the potential target cell population
may increase, while there is a simultaneous decrease in the cells thought to
suppress tumorigenic activity.
While there is undeniably a genetic component to all cancers, the
accumulation of mutations with age is insufficient to explain the
age-dependent increase in breast cancer incidence (LaBarge et al., 2015;
Stephens et al., 2012). In opposition to this conventional view, the
age-related susceptibility to breast cancer might follow the adaptive
oncogenesis model, where the reciprocal dynamic between the
microenvironment and the progenitor is skewed, leading to a decrease in
breast tissue fitness and an increase in susceptibility to tumorigenesis (Figure
13) (Henry et al., 2011). We hypothesize that age-associated responses to
microenvironment changes arise due to fundamental changes in signal
transduction pathways in stem/progenitor cells, which promotes
susceptibility to malignant transformation.
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Figure 13: Conventional and adaptive oncogenesis models for
tumorigenesis. Conventional View: Aging primarily contributes to increased
cancers by facilitating the accumulation of oncogenic mutations (red cells).
Adaptive Oncogenesis Model: The ability of an oncogene to induce cancer is
context specific. If cellular fitness decreases as a result of aging, the acquisition
of an oncogenic mutation could be adaptive. In this context, these cells would
be selected for leading to carcinogenesis. From (Henry et al., 2011).
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2 Hypothesis and Aims
The central hypothesis of this dissertation is that a novel effect of aging is a
defective stem cell regulation by the microenvironment. The main objectives
of the presented work were to identify age-related changes in mammary stem
and progenitor cell responses to the microenvironment, and define breast
epithelial cell subpopulations that change with age. Thus, the following aims
are outlined:
A- Determine the role of Axl signal transduction in human
mammary stem and progenitor cell differentiation
Previous results indicate that Axl expression may be associated with
epithelial plasticity that drives both malignant progression and metastatic
colonization. As the EMT gene program has been associated with mammary
epithelial stem cell activity and embryonic stem cells, we hypothesized that
Axl is a regulator of stem cell functions in normal breast epithelial cells. We
reasoned that genes associated with breast carcinoma plasticity might serve
roles in normal breast epithelial homeostasis. Samples from the LBNL
HMEC Resource are analyzed to evaluate the possibility that Axl could be
present in rare human mammary epithelial cells that are enriched for
multipotent progenitor activity.
B- Determine the effect of microenvironmental changes on human
mammary progenitor cell differentiation
In light of the findings that differentiation-defective cKit-expressing
multipotent progenitors accumulate with age, and proportions of daughter
myoepithelial and luminal epithelial cells shift with age (Garbe et al., 2012),
we hypothesized that these age-associated changes render aged breast tissue
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susceptible to malignant progression. Matrix stiffness is mechanistically
important in breast cancer progression and the physiological range of elastic
modulus in breast plays an instructive role in the differentiation of normal
mammary progenitors. We propose that perturbing matrix stiffness may
reveal aging phenotypes due to altered cell mechanics pathways. We aimed
to determine if the three steps of cell mechanics (mechanosensing,
mechanotransduction and mechanoresponse) are altered with age using
samples from the LBNL HMEC Resource.
C- Characterize the age-related cell subsets at high-resolution
We previously demonstrated that post-menopausal LEP frequently express
some K14, as well as other markers typically associated with myoepithelial
cells. Moreover, age-dependent changes in the efficiency of
YAP/TAZ-mediated mechanotransduction may help drive that phenotype of
aging. More YAP has been observed in the nucleus of older LEP in vivo
(Pelissier et al., 2014) which homolog TAZ is associated with basal
differentiation transcription program (Skibinski et al., 2014). However, a
quantitative understanding of the phenotypic and functional heterogeneity
within aged tissues is lacking, which would allow us to pinpoint
subpopulations of cells that are changing during the aging process and that
may be missed in population-average experiments. We hypothesized that
human mammary epithelial cells exhibit age-related phenotypic heterogeneity
that may be implicated in breast cancer susceptibility. Thus, phenotypical
identification of cells in heterogeneous populations requires simultaneous
multiparametric measurement of distinguishing markers at the single cell
level. We aimed to analyze LBNL HMEC samples at high resolution using
mass cytometry.
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3 Summary of Results
Paper I
Multipotent mammary stem cell activity requires Axl receptor tyrosine kinase
in mice and humans. Engelsen, Wnuk-Lipinska, Pelissier, etal., Submitted.
We evaluated the hypothesis that Axl is a regulator of stem cell functions in
normal breast epithelial cells; serving an unappreciated role in the
maintenance of the normal mammary epithelial hierarchy and conferring
stem cell traits to breast cancer cells. This study aimed to analyze
dissociated primary HMEC from the Aging Resource to determine the
potency of Axl-enriched population and to modulate Axl signal transduction
to understand its role in normal mammary epithelia.
Main methods:
HMEC populations comprising differentiated LEP, MEP and mammary
stem/progenitor epithelial cell populations were resolved by staining for
established surface marker combinations. TDLU-forming assays were
performed to determine the potency of Axl-enriched population by culturing
in 3D Matrigel for 10-20 days at which time morphology is assessed by phase
microscopy and stained with a number of intracellular markers (e.g. keratin)
and evaluated by laser scanning confocal microscopy to determine the
presence of cells representative of the two main mammary cell lineages, LEP
and MEP. Axl signal transduction was modulated using a selective Axl
kinase inhibitor (BGB324, BerGenBio AS), function-blocking monoclonal
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antibody (MAB 10C9, (Kirane et al., 2015)) and warfarin (ligand binding
inhibitor, (Kirane et al., 2015)). Next, we hypothesized that a juxtacrine
Gas6-Axl signaling axis regulates adult regenerative homeostasis between
Gas6-producing LEP and adjacent Axl-expressing suprabasal stem cells. To
test this, we treated 3 week old mice with warfarin (1mg/ml in drinking
water) for 4 weeks to block vitamin K-dependent glutamic acid
γ-carboxylation of Gas6 that is required for Axl receptor activation.
Results:
Axl–expressing HMEC represented 1-6% of the total HMEC population from
different patients, residing mainly within the EpCAM+/CD49f+
subpopulation. Moreover, all Axl+ HMEC co-expressed cKit, with
cKit+Axl+ HMEC representing 16% of the total cKit+ progenitor cells. We
isolated cKit+ HMEC progenitors and performed in vitro serial
mammosphere transfers and clonal formation of multi-lineage acini in 3D
laminin-rich ECM (lrECM) in the presence of Axl tyrosine kinase inhibitors
(TKIs). Secondary mammosphere formation was significantly reduced by
treatment with BGB324. cKit+ HMEC embedded at clonal density in
lrECM displayed multipotent progenitor activity, forming LEP–MEP
bilayered acini. These results indicate that cKit+/Axl+ mammary epithelial
cells exhibited self-maintenance and multipotent activity that required Axl
kinase activity.
Next, we assessed the differentiation profile of Axl-inhibited HMEC using
BGB324. As observed before, LEP proportion decreases with culture passage
(Garbe et al., 2012). However, addition of Axl TKI to HMEC cultures slowed
loss of LEP.
Finally, we sought to determine if Axl contributes to the maintenance of
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mouse multipotent progenitors in the mammary gland. Warfarin treatment
resulted in a significant decrease in the number of terminal end bud (TEB)
structures, where mouse mammary multipotent/stem epithelial cells are
thought to reside.
Conclusions:
Collectively, this study identifies Axl signaling as a novel regulator of the
regenerative stem cell state that is conserved in human and mouse mammary
epithelia. Our results suggest a unique mode of adult luminal cell
homeostasis governed by a Gas6-Axl signaling axis where adjacent
differentiated cells determine stem cell maintenance and luminal potency. We
establish for the first time that Axl signal transduction is required for the
multipotent activity of Axl-expressing human mammary epithelial progenitor
cells. These findings provide a novel mechanistic rationale whereby Axl
signaling contributes to sustain the phenotypic plasticity characteristic of
normal breast stem/progenitor and malignant carcinoma cells.
Paper II
Age-related dysfunction in mechanotransduction impairs differentiation of
human mammary epithelial progenitors. Pelissier, etal., Cell Reports, Jun
26;7(6):1926-39 2014.
We hypothesized that perturbing matrix stiffness reveals aging phenotype
due to altered cell mechanics pathways. We aimed to determine if the three
steps of cell mechanics are altered with age in mammary progenitors using
samples from the LBNL HMEC Resource. Since all Axl+ HMEC co-express




Polyacrylamide (PA) gel concentration was tuned to mimic soft physiological
stiffness range (200Pa to 2350Pa) (Tse and Engler, 2010). Multipotent
progenitor population from women under 30 years old (y) and women over
55y were fluorescence-activated cell sorting (FACS)-enriched using the cKit
marker and cultured for 48h onto PA gels or glass (>3GPa) control. LEP
and MEP population proportions and proliferation were quantified using
immunofluorescence and are the output of the mechanoresponse.
Mechanosensing was measured using stress fibers and focal adhesions
formation. YAP and TAZ are transcription co-activators and belong to the
Hippo pathway, they shuttle to the nucleus with increasing stiffness and
activate target gene expression responsible for the various mechanoresponses.
Mechanotransduction was quantified via YAP and TAZ translocation to the
nucleus.
Results:
With increasing stiffness, multipotent (MPP) progenitors gave rise to more
MEP and less LEP. This is a protective mechanism, as the matrix was tensed
to approach a malignant tissue stiffness, the progenitors differentiate toward
tumor-suppressive MEP. This phenotype was observed only in younger
women. While mechanosensing was working equally in the two age groups,
YAP and TAZ translocated into the nucleus of younger women cultured onto
substrata with increased stiffness and only into the nucleus of older women
plated onto >3GPa condition. On this extraphysiological condition, older
MPP differentiated toward more LEP. Older multipotent progenitors need to
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be stressed with extraphysiologically stiff substrata to reveal their
YAP/TAZ-dependent bias toward LEP. This result was consistent with our
observation in vivo that YAP tended to be located in LEP with increased
age.
We made some genetic modifications in the normal progenitors to make them
immortal, which is a rate-limiting step in cancer progression. This act of
transformation rejuvenated the older cells’ ability to respond to physiological
changes stiffness, but the immortal older cells still exhibited the same
tendency to make weird luminal-like progeny on stiffer matrices, whereas the
immortal younger cells still made basal-like cells.
Conclusions:
Matrix rigidity is a determinant of mammary epithelial progenitor
differentiation. Exposure of progenitors to mechanically tuned culture
substrata revealed two fundamental changes that arise in MPP with age: (1)
the mechanical trigger point for activation of YAP/TAZ increases, and (2)
the YAP/TAZ-dependent differentiation programs become distinct. Our
experimental approach took advantage of tuned mechanical perturbations of
matrix to functionally probe the HMEC, but more broadly these results
revealed that aging fundamentally alters Hippo pathway regulation.
Accumulation of MPP with age may be attributed to inefficient transduction
of differentiation cues through the Hippo pathway.
Paper III
High dimensional analysis of age-related phenotypic diversity in human
mammary epithelial cells. Pelissier, etal. Manuscript.
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The dynamic reciprocity between HMEC progenitors and the
microenvironment regulation is altered with age. This alteration results in
accumulation of progenitors with a basal differentiation bias toward LEP.
These luminal cells acquire basal traits and thus exhibit a phenotypic
divergence. The phenotypic heterogeneity within a tissue reflects the
phenotypic divergence between different cell states. Hence quantifying
age-dependent phenotypic heterogeneity may reveal specific subpopulations
of cells that accumulate with age.
Main methods:
Standard immunofluorescence and flow cytometry methods are limited to
relatively few parameters. Mass cytometry is a recent technology that allows
high-content multiparametric analysis of single cells in complex
heterogeneous biological system (Bandura et al., 2009). A test-set of HMEC
samples from forty-four women from 16 to 91y was analyzed at once using a
multiplexing approach called mass-tag cellular barcoding (MCB). We
selected 10 highly informative surface markers that captured the
lineage-heterogeneity in HMEC. We added 12 antibody probes against
intracellular phosphorylation, 4 antibody probes against the Hippo pathway
and 3 antibody probes against cell cycle and apoptosis pathway, thus
allowing simultaneous measurement of surface phenotype and signaling
behavior in single cell. The data is analyzed using t-distributed stochastic
neighbor embedding (tSNE), PhenoGraph, and Citrus for the identification
of stratifying subpopulations changing with age.
Results:
We demonstrated in high definition that luminal and myoepithelial
58
populations had lineage-specific phenotypic divergence and high intra-lineage
heterogeneity. Unsupervised population partitioning revealed age-dependent
clusters, only in the luminal compartment, that were more abundant with
age. These seven clusters had specific marker expression signature and were
characterized as: K14high/K19low, Proliferative LEP, Basal LEP, Keratinlow,
pS6 luminal, Keratinlow-S and Axlhigh. The aged luminal cells manifested a
marker expression signature that correlated with an enhanced basal
phenotype. Using this data set we built an unsupervised classification model
that correctly assigned more than 80% of the samples into their correct
age-group. Further, we found age-related changes in luminal progenitor cells,
supporting the notion of accumulated age-altered stem/progenitor cell
populations during aging. Hence, high-dimensional analysis of normal human
mammary epithelial cells revealed a remarkable age-related phenotypic
divergence in the luminal and luminal progenitor cells.
Conclusions:
We describe the first multiparametric analysis of complex heterogeneous
HMEC populations. Taken together, high-dimensional analysis of normal
human mammary epithelial cells revealed an age-related divergence in the
luminal and progenitor populations. This study presents a unique in-depth
perspective of age-related phenotypic diversity of human mammary epithelial
cells and pinpoints a specific progenitor and luminal subpopulation that may
be an origin of age-related breast cancer.
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4 Methodological Considerations
4.1 Human mammary epithelial cells
It is important to be able to empirically examine the cell and molecular
consequences of aging in normal human epithelia because most carcinomas
are age-related. Wild-type mice are typically resistant to cancers, murine
models of breast cancer do not completely model the steps of cancer
progression in HMEC (Stampfer et al., 2013), and most inbred strains
exhibit tumor incidence curves consistent with sporadic tumor genesis. In
addition, it is notable that there are morphological differences between
mouse and human mammary parenchyma (Figure 7). Thus, mice may not be
an optimal model for studying the genesis of age-related breast cancers.
Normal human mammary cells can be obtained directly from surgical tissues
(reduction mammoplasties, mastectomies, normal biopsies) and milk fluids.
Early passage HMEC cultures are provided from an existing bank of
specimens (hmec.lbl.gov). These pre-stasis HMEC cultures established from
organoids are uniquely well- characterized, multi-lineage strains with normal
finite-lifespan. Early passage populations from reduction mammoplasty
contain a mixture of cells with marker of myoepithelial, luminal and
progenitor lineages (Figure 14). Both luminal and myoepithelial populations
develop from progenitor cells, a small fraction of the cells in the gland that
retain the ability to divide. The HMEC resource is a unique system to
understand normal breast aging and its correlated risk to breast cancer. A
recent M87A media support long-term pre-stasis growth of 60 population
doubling (PD). However, the luminal cells do not maintain active growth
with long-term passage (Garbe et al., 2009). The Aging Resource makes
large standardized HMEC batches from individual specimen donors at
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passages 2–5. These uniform batches permit reproducible large-scale and
high-throughput experimentation with normal HMEC from multiple
individuals of different ages. Currently, cultures from 50 individuals of
women ranging in age from 14 to 91 have been initiated (Stampfer et al.,
2013).
Figure 14: HMEC cells in culture. Morphologically, the border of MEP
is more delineated, and they have an ellipsoid shape. LEP are more compact
than MEP. An organoid is shown. Image from Mark LaBarge.
It is important to note that all the HMEC strains from the American Type
Culture Collection (ATCC) are post-stasis: they have bypassed at least two
major barriers to malignancy and thus are not normal. In addition, the
MCF10a cell line has been widely used and considered as normal. However,
it is immortalized and thus not normal (Soule et al., 1990). This explains
why research on these cell lines cannot be fully translated. In our study, we
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used MCF10a to induce EMT using Slug over-expression due to the ease of
transformation of this cell line as compared to normal HMEC.
4.2 Cell segmentation with Matlab
The identification of LEP (K19+/K14-) and MEP (K19-/K14+) at the
single cell level in immunofluorescence staining images requires the absolute
quantification of each marker intensity for each cell. In our
immunofluorescence settings, K19 and K14 are visualized in the green and




. This ratio is negative for green cells,
positive for red cells and zero for yellow cells (co-expression). A manual
quantification of each cell using an image analysis program like ImageJ is
time-consuming and is prone to bias. Thus, we developed an image
segmentation method using Matlab. The program analyzes each image
(Figure 15A) and applies a threshold to segregate the cells from the
background (Figure 15B). Next, it finds cell nuclei using the DAPI channel
(Figure 15C). The nuclei and the background are marked as "valleys" and the
cells as "mountains" (Figure 15D). Then, a marker-controlled watershed
segmentation is applied to dissociate "valleys" from "mountains" by filling
"water" in between. Each cell is segmented and labeled and quantification of
each fluorescence channel is obtained (Figure 15E). This program has been
used additionally in (Sputova et al., 2013) and (Garbe et al., 2012) and has
been modulated to measure cell feature and YAP/TAZ nucleus and
cytoplasmic level and has been also used in (Lin et al., 2015). The
description of the code is found in the Supplemental Information of Paper II.
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Figure 15: Marker-controlled watershed cell segmentation with
Matlab. (A) Immunofluorescence of HMEC in culture using the MEP and
LEP markers K14 (red) and K19 (green) respectively. The nuclei are stained
with DAPI (blue). (B) Background segregation. (C) Nuclei segmentation.
(D) A mask of the nuclei and the cell contour are overlaid on top of the
image to represent the "valley" and the cells the "mountains". (E) Segmented
labeled image. Each color indicates an unique segmented object with unique
properties (e.g. channel fluorescence, shape, area etc.). See also Supplemental
Information of Paper II.
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4.3 Immortalized cell lines
In cancer research, the majority of immortal cell lines used are either
expanded from tumors or become genetically unstable, making it impossible
to understand the process of a cell’s malignant transformation and its
underlying causes.
Efficient non-clonal immortalization of normal HMEC can be achieved by
directly targeting the two main senescence barriers encountered by cultured
HMEC. The stress-associated stasis barrier is bypassed using shRNA to
p16INK4; replicative senescence due to critically shortened telomeres was
bypassed in post-stasis HMEC by c-Myc transduction (Garbe et al., 2014).
The resultant non-clonal immortalized lines have normal karyotypes and lack
the confounding gross genomic changes commonly seen in tumors,
tumor-derived cell lines, and clonally derived in vitro immortalized lines.
Pre-stasis HMEC strains 184D, 240L, 122L, and 805P were transduced with
retroviruses that expressed either p16 shRNA (p16sh) or cyclinD1/CDK2
(D1), or with a control empty vector. These gave rise to the post-stasis
cultures which were transduced either with an empty vector control, or a
c-Myc expressing retrovirus in order to transactivate telomerase, giving rise
to the non-clonal immortal lines 184Dp16sMY, 240Lp16sMY, 240LD1MY,
122Lp16sMY, 122LD1MY, and 805Pp16sMY (Lee et al., 2015).
4.4 Mouse models
Ethics statement
All mouse experiments were approved under the surveillance of the
Norwegian Animal Research Authority. The participants and the candidate,
who worked with live vertebrate animals for scientific purposes, were trained
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and certified by the Federation of European Laboratory Animal Science
Associations.
In vitro analysis do not entirely recapitulate physiological context. Although
mice are not an optimal model for studying age-related breast cancer, in vivo
model systems are necessary to validate in vitro findings. Mouse models are
widely used in translational cancer research due to short gestation period,
low maintenance cost and ease of genetic manipulations (Cheon and Orsulic,
2011). In our studies we have used different types of animals, such as
athymic nude mice. These hairless mice due to the Foxn1 gene mutation,
were used to easily engraft xenogeneic cell lines. Balb/c mice have a normal
immune system and are also reported as having a low mammary tumor
incidence. These mice were used to study normal mouse mammary gland
development and its perturbation using tyrosine kinase inhibitors targeting
Axl. Genetically engineered mouse strain of B6.129P2 − Axltm1Dgen carries a
targeted LacZ gene knock-in mutation that disrupts Axl protein expression.
As a genetic background, strain C57BL/6 was used due to the ease of
propagation, availability of congenic strains and their robustness which make
them the most commonly used rodent model in research (Brayton et al.,
2012).
We hypothesized that a juxtacrine Gas6-Axl signaling axis regulates adult
regenerative homeostasis between Gas6-producing LEP and adjacent
Axl-expressing suprabasal stem cells. To test this hypothesis, we treated 3
week old Balb/c with warfarin (1mg/L in drinking water) to block vitamin
K-dependent glutamic acid γ-carboxylation of Gas6 that is required for Axl
receptor activation. After 4 weeks of treatment, mammary glands from the
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pubescent mice were analyzed.
4.5 Ensemble-averaged measurements can mask
information contained in heterogeneity
Phenotypic differences among cells are always present at a high resolution
of inspection. Population-averaged assays are powerful tools in biology,
enabling the identification of components and interactions within complex
metabolic, signaling, and transcriptional networks. The problem occurs
when the ensemble-averaged measurement poorly reflects the states of the
majority of the cells, subpopulations of cells, or even single cells (Figure
16). This can occur, for example, when the population contains several
dominant, yet phenotypically distinct subpopulations. In order to measure
tissue heterogeneity, the number of parameters analyzed should be augmented.
Standard immunofluorescence and FACS technique are unfortunately limited
to relatively few parameters.
4.6 Mass cytometry
Mass cytometry is a recent technology that allows high-content
multiparametric analysis of single cells in complex heterogeneous biological
system. Mass cytometry increases the number of parameters that can be
measured, reduces overlap between channels and eliminates background
fluorescence (Bandura et al., 2009; Ornatsky et al., 2010). The approach is
based on attaching specially designed multiatom elemental tags to
antibodies, in place of fluorescent labels, and takes advantage of the high
resolution, sensitivity, and speed of analysis of inductively coupled plasma
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Figure 16: Ensemble-averaged measurements can mask information
contained in heterogeneity. (A) A population mean (μ) may poorly
represent the majority of cells. (B) Heterogeneity and function: single-cell
measurements allow cells to be represented as points in a high-dimensional
space. Cell populations can be partitioned into distinct regions of feature
space. Illustrated is a decomposition into two subpopulations, S1 and S2.
From (Altschuler and Wu, 2010)
.
time-of-flight mass spectrometry (ICP-TOF-MS). The CyTOF system
(Fluidigm, formerly DVS Sciences) measures the abundance of metal isotopes
tagged to antibodies (Lou et al., 2007). Signaling pathways, cell cycle state,
cell viability, using platinum-based viability reagent (Fienberg et al., 2012)
and many other cellular pathways can be simultaneously interrogated
(Bendall et al., 2011). In order to avoid staining over multiple samples
leading to staining heterogeneity and high cost, MCB is adapted
(Bodenmiller et al., 2012) (Figure 17A).
However, it is difficult to visualize such high numbers of dimensions in a
meaningful manner. Single-cell data are often examined in two dimensions at
a time in the form of a scatter plot. Yet, as the number of parameters
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Figure 17: Summary of experimental design. (A) Samples of HMEC
from 44 women are analyzed at once using MCB, stained using antibodies
labeled with isotopes and analyzed using mass cytometry. (B) Strategy to
cluster high-dimensional single-cell data and identify age-related phenotypic
divergence.
increases, the number of pairs becomes overwhelming. Dimensionality
reduction techniques such as tSNE help visualize the data (Figure 17B).
Using tSNE, each cell is represented as a point in high-dimensional space.
Each dimension is one parameter (that is, the expression level of one
protein). An optimization algorithm searches for a projection of the points
from the high-dimensional space into two dimensions such that pairwise
distances between the points are best conserved between the high- and
low-dimensional spaces (Amir et al., 2013). In addition, the PhenoGraph
algorithm robustly partitions high-parameter single-cell data into
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phenotypically distinct subpopulations (Levine et al., 2015). Finally, Citrus
(cluster identification, characterization and regression) is a data-driven
approach for the identification of stratifying subpopulations in
multidimensional cytometry data-sets (Bruggner et al., 2014). Citrus applies
hierarchical clustering to identify clusters of cells within the dataset,
calculating descriptive features of each cluster, and then applying regularized
regression model to determine which cell subsets’ behavior are correlated
with aging. Shortly, the Citrus algorithm combines all samples into one
aggregate dataset before identifying cell populations by hierarchical
clustering of phenotypically similar cells. Next, cells are assigned back to the
individual samples and cluster abundance or marker median is calculated.
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5 Discussion
Our functional characterization of Axl in Paper I supports a model where
Axl contributes to the maintenance of progenitor and stem cell traits in
normal mammary epithelial cells. Axl is expressed by 16% of the cKit+
epithelial progenitor population and all Axl+ HMEC co-expressed cKit, thus
Axl represents a marker of stem cell higher in the progenitor hierarchy and
basally located. These cKit+ progenitors are tightly regulated by the
microenvironment and more precisely by substrate stiffness. Their
accumulation with age may be attributed to the inefficient transduction of
differentiation cues through the Hippo pathway as described in Paper II.
Finally, clusters of cells accumulating with age with a basal phenotype, were
identified in high definition in Paper III and were found only in the luminal
and progenitor compartments.
5.1 The role of Axl in normal mammary gland
We identified Axl signaling as a novel regulator of the regenerative stem cell
state that is conserved in human and mouse mammary epithelia. Our results
suggest a unique mode of adult luminal cell homeostasis governed by a
Gas6-Axl signaling axis where adjacent differentiated cells determine stem
cell maintenance and luminal potency.
We showed that Axl-expressing multipotent epithelial progenitor cells
co-express cKit and cluster independently by gene expression and
immunophenotyping. Gas6 secretion by LEP represents a local source of
ligand within the ductal bilayer (Ji et al., 2011). Hence, Gas6 production by
LEP could conceivably regulate epithelial lineage commitment by
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juxtapositioned Axl-expressing progenitors.
Using mass cytometry we identified an Axl+ cluster of cells in the cKit+
progenitors, as previously observed. On another hand, Axl has been
previously identified as a YAP downstream target (Xu et al., 2011). We have
shown that Axl expression correlates with YAP in MEP. This phenotype also
validates the hypothesis of a luminal regulation of Axl commitment.
However, we did not observe Axl expression in MEP in vivo, this phenotype
might be the results of a culture adaptation as MEP cultured on a
extraphysiological substrata (tissue culture dish) would activate YAP and
thus Axl. On another hand, HMEC were permeabilized before analyzed with
mass cytometry, thus the observed Axl expression may be intracellular,
although we did not observe Axl mRNA in MEP using RNAscope. In our
hands, HMEC from a young woman (19y) treated with Verteporfin, a
YAP/TEAD interaction inhibitor, exhibited a decrease in Axl and K14 and
an increase in K19 expression in both LEP and MEP (Figure 18). These
results need further investigation.
Our results show that Axl is expressed by rare stem/progenitor cells and
regulates multipotent progenitor activity, supporting the concept that Axl
signaling contributes to the maintenance of the stem-progenitor cell state
within the normal breast epithelial hierarchy. Hence Axl expression during
breast cancer development can be viewed as a consequence of the
reactivation of stem/progenitor-related gene programs in tumor cells.
Our following work was mostly focused on cKit+ progenitor population
which contains Axl+ stem cells. Axl+ stem cells reside in specialized niche in
a more basal location and cKit+ progenitors are more committed progenitors
residing outside of a niche. This may explain why the Axl+ stem cell
population is lost after passaging HMEC in vitro, while cKit+ progenitors
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Figure 18: YAP/TEAD inhibition with Verteporfin. Histograms of Axl,
K14 and K19 expression in HMEC treated with DMSO or 20μM Verteporfin
for 15min measured with mass cytometry. LEP and MEP were manually
gated.
still give rise to both LEP and MEP daughter cells. In addition, the
age-related increase in cKit+ progenitors was not observed in cKit+/Axl+
stem cells (Figure 19) which supports the hypothesis that Axl+ stem cells
reside in a niche that is more protected from microenvironment changes.
Figure 19: Proportion of cKit+ and cKit+/Axl+ as a function of
age. N=5, ** p=0.0021.
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5.2 Matrix stiffness exquisitely directs mammary
progenitor differentiation
Changes to the mechanical microenvironment likely have pleiotropic effects on
multiple breast cell types. High breast stiffness and density are correlated with
increased risk and cancer progression (Yu et al., 2011). Increased stiffness also
can induce adipocyte progenitors to differentiate into fibroblasts, which can
positively feedback to further increase tissue stiffness (Chandler et al., 2012).
Our results document the role of YAP/TAZ transcription factors as drivers of
modulus- dependent differentiation in human mammary epithelial progenitors
and suggest that YAP/TAZ activity favors differentiation into MEP and other
basal cell types. A previous report showed the role of mechanical environment
in the differentiation of mammary progenitors (Lui et al., 2012), however the
authors used an immortalized cell line, MCF10a which is already transformed,
thus not considered as normal.
Studies have shown that normal breast tissue is much more compliant than
tumor tissue and it turns out that stiffer tissue enhances malignant behavior
of cancer cells (Paszek et al., 2005). Normal progenitors from younger women
would differentiate into myoepithelial/basal cells as the matrix was tensed to
approach a physiological, albeit malignant, tissue stiffness. This is a protective
mechanism because myoepithelial cells are tumor suppressors (Gudjonsson
et al., 2002). Thus, when the breast stiffness increases and reaches a malignant
stiffness, cKit progenitors differentiate toward MEP, leading to their decrease
in proportion. We may hypothesize that this protective mechanism is altered
in older progenitors leading to their accumulation (Figure 20).
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Figure 20: Linear regression plots of MPP proportion as a function
of modulus and age. The accumulation of progenitors with age may be
explained by the altered response of progenitors to mechanical cues. Adapted
from (Pelissier et al., 2014).
5.3 Immortalization restores responsiveness to
physiological stiffness in older HMEC
When older cKit progenitors were exposed to extraphysiologically stiff
substrata, they exhibited LEP-biased differentiation, the exact opposite of
the younger progenitors. Age-dependent differentiation patterns were
preserved in immortal young and old HMEC, but the mechanotransducive
mechanism was notably rejuvenated in older immortal cells, enabling them
to proliferate increasingly as matrix modulus approached that of a tumor.
YAP/TAZ were required for shifting production in favor of MEP in younger
and LEP in older MPP on the stiffer surfaces. We hypothesize that the
distinct differentiation responses of younger and older MPP reflect
age-dependent epigenetic landscapes. Indeed, normal HMEC exhibit
age-dependent gene expression patterns consistent with the concept of
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age-dependent epigenetic states (Garbe et al., 2012). In addition, after older
HMEC were made non-malignantly immortal, the Hippo pathway regained
sensitivity that allowed them to increase proliferation as matrix rigidity
approached an elastic modulus that was on a par with breast tumors.
Stromal feedback loops can result in formation of stiffened regions; if such
regions already contained an accumulation of aged progenitor cells carrying
errors predisposing them to immortality, they could create an environment
that promotes development of age-related luminal subtype breast tumors.
5.4 The role of the Hippo pathway in age-related
mechanoresponses
The accumulation of cKit-progenitors with age could be attributed to the
inefficient transduction of differentiation cues through the Hippo pathway.
At low cell density, decreased LATS2 activity, which causes YAP and TAZ to
translocate to the nucleus, depends upon F-actin SF formation (Wada et al.,
2011). Young and old MPP formed SF and FA equally well in response to
increasingly stiff substrata, within the physiologically relevant range.
Therefore the stoichiometry of MST1/2, LATS2, and AMOT may change
with age, dampening the activation of YAP and TAZ. In our hands, MST2
protein expression was consistently higher in post-menopause MPP. The
Hippo pathway may have a rheostat-like mechanism that allows
mesenchymal stem cells to distinguish between the relative stiffness of
adipose, muscle, and bone tissues, and also allow mammary epithelial
progenitors to respond to a much narrower range of elastic modulus. Each of
these tissue microenvironments differs in their matrix composition as well as
their elastic modular range, and there is a reasonable expectation that Hippo
pathway activity is fine-tuned by combinations of ECM and growth factors.
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Further study of the interaction between the Hippo pathway with
combinations of microenvironmental elements may reveal components of the
mechanical response rheostat and reveal the basis for its age-related
dampening.
5.5 The paradox of mammographic density and breast
cancer risk
Mammographic density is a major risk factor for a breast cancer subtype
(Bertrand et al., 2013; Maskarinec et al., 2006). Paradoxically, while breast
cancer risk increases, radiographic density of breast tissue tends to decrease
with age, consistent with increased adipose and decreased connective tissues
(Benz, 2008). This might be hypothetically explained by the fact that the
local stiffness of the mammary epithelia may not correlate with the overall
breast density. Indeed, with age, the breast undergoes sagging or ptosis.
While the mammary gland experiences a decrease in stromal connective
tissue, the epithelial sheets may feel a stretch due to a decrease in stromal
support. This stretch may be translated as a stretch at the cellular level
which has been shown to inhibit the Hippo pathway thus activate YAP/TAZ
in the nucleus (Figure 21). This may explain why we observed higher level of
YAP in the nucleus of HMEC from older women in vivo. We can speculate
that with age, YAP/TAZ activation might result in a luminal differentiation
with basal traits. This activation may lead to oncogenic pathway activation
and malignancy.
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Figure 21: Stretching of an epithelial monolayer overcomes
YAP/TAZ inhibition and growth arrest in contact-inhibited cells.
Mammary epithelial cells were plated on the stretching device. After 2 days,
cells were subjected to 6 hours of static stretching (p > 0). The plot shows
proportion of cells displaying preferential nuclear YAP/TAZ localization (N,
black), even distribution of YAP/TAZ between the nucleus and the cytoplasm
(N/C, gray), or prevalently cytoplasmic YAP/TAZ (C, white). Adapted from
(Aragona et al., 2013).
5.6 The mammary gland exhibits an extensive range
of heterogeneity
Adult tissues comprise populations of cells that can be heterogeneous in their
phenotypic properties (Altschuler and Wu, 2010), and the mammary gland is a
prototypical example of a heterogeneous tissue, possessing considerable spatial
and temporal variability within both LEP and MEP populations. For example,
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neighboring cells in healthy tissue can differ markedly with respect to their
expression of adhesion molecules, cytoskeletal proteins, hormone receptors,
and the activation of specific signaling pathways (Bloushtain-Qimron et al.,
2008; Keller et al., 2010; Moreira et al., 2010; Shehata et al., 2012).
In Paper III, high-dimensional partitioning of HMEC from 44 women revealed
four luminal and nine myoepithelial subpopulations, in addition to a double-
positive (DP) progenitor subpopulation expressing both K14 and K19 markers
previously observed in vivo (Villadsen et al., 2007). These subpopulations
exhibit a high variability of surface and signaling marker expression, within
their lineage-dependent range of expression. The mammary epithelium is more
heterogeneous than initially perceived. An understanding of these different
subpopulation of cells and their microenvironment regulation is essential for
understanding the origins and the cellular context of human breast tumors.
5.7 Luminal cells exhibit basal characteristics with age
The basal cell types are not necessarily exclusive to myoepithelial cells, and
may include luminal cells that express K14 and other basal-associated markers,
which we and others have observed (Santagata et al., 2014). In Paper II, older
progenitors needed to be stressed with extraphysiologically stiff substrata to
reveal their YAP/TAZ-dependent bias towards LEP, which was consistent
with our observation in vivo that YAP tended to be located more in LEP
with increased age. In younger women, YAP was clearly in the nuclei of
MEP. These new data suggest that age-dependent changes in the efficiency
of YAP/TAZ-mediated mechanotransduction may help drive that phenotype
of aging. In addition, forced expression of TAZ in luminal cells induces
them to adopt basal characteristics, and depletion of TAZ in basal and/or
myoepithelial cells leads to luminal differentiation (Skibinski et al., 2014).
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In Paper III, subpopulations of LEP accumulating with age exhibited age-
specific signatures. Strikingly, we observed a linear increase in YAP expression
in LEP with age (Figure 22). Interestingly, no age-dependent subpopulations
Figure 22: YAP expression increases with age in LEP. Using mass
cytometry in Paper III we observed a linear increase of YAP marker expression
with age in luminal cells.
where found in the MEP lineage. Specific age-related signatures in luminal
clusters correlated with basal phenotype, migration and proliferation potential.
Importantly, we built an unsupervised classification model that correctly
assigned more than 80% of the samples into their correct age-group based on
alterations in phenotypic diversity.
Altogether, high-dimensional partitioning of the mammary epithelia revealed
luminal subpopulations with skewed differentiation and a basal phenotype
that accumulate with age. These cells exhibit hallmarks of aging, and may be
the progeny of altered luminal progenitors which have a skewed differentiation.
This aging phenotype could be validated in vivo. A subpopulation of LEP
accumulating with age with basal characteristics (increased K14 and decreased
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K19 expression) was identified in vivo and these markers could be used to
perform a morphometric context classification.
5.8 Evidence of age-dependent phenotypic divergence
in HMEC progenitors
In Paper III, specific markers in the gene expression signatures were found in
clusters of progenitors accumulating with age: K8/18, CD133, cKit, YAP and
HER2. These markers are connected with stemness, stress, migration and
malignancy. This finding correlates with the fact that cKit over-expression
prevents normal differentiation (Regan et al., 2012) and may explain the
accumulation of cKit progenitors with age. CD133 was the marker which
changed the most with age. CD133 was found to be a luminal progenitor
marker (Hilton et al., 2012; Raouf et al., 2008). In addition, CD133 is expressed
in certain types of breast cancer, in which CD133-positivity seems to identify
a restricted subgroup of tumor stem cells (Wright et al., 2008). As previously
described, a high YAP expression in luminal biased-progenitors might result in
a luminal differentiation with basal traits. Moreover, over-expression of HER2
has been shown to play an important role in the development and progression
of certain aggressive types of breast cancer (Ménard et al., 2000). More
recently, a group showed that in luminal breast cancer, hormonal treatment
lead to a reduction in ER levels promoting cancer stem cell phenotype
(CD133high and CD44low) (Sansone et al., 2016). This results correlate
well with the fact estradiol serum concentration decreases with age (van
Landeghem et al., 1985) and we observed an increase in CD133high and
CD44low cell proportion. These cells are highly suspected for the implication
as cells-of-origin for breast cancers.
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5.9 Breast cancer susceptibility and prevention
When we examined human mammary epithelia at high definition, aging
was found to be associated with the accumulation of mammary epithelial
progenitor cells, which are putative cells-of-origin for breast cancers, and
with the presence of fewer myoepithelial cells, which can suppress malignant
tumor-forming cells. Thus, during the aging process, the population of
cells potentially targeted for transformation is increased, and there is a
simultaneous decrease in tumor-suppressive cells, which suggests a mechanism
that leads to increased susceptibility to malignant progression (Figure 23).
Altogether, the reciprocal dynamic between the microenvironment and the
progenitor is skewed, leading to an increase selection for adaptive mutations
and a decrease in tumor suppressive mechanisms (Henry et al., 2011). Thus,
with age, a higher susceptibility to breast cancer may be attributed to a
mis-regulation of progenitors by their microenvironment, which is a previously
unappreciated hallmark of aging. The ultimate goal would be to prevent
breast cancer in a non-invasive way. However, the fact that seven out of eight
women >50y will not be affected by breast cancer, reveals the difficulty of
identifying susceptibility factors and not confounding them with normal aging
markers.
The therapeutic targets for the current forms of prevention are hormone-
related (Fisher et al., 1998; Powles et al., 2007). In addition, in Paper I, we
observed that a cohort of post-menopausal women treated with warfarin had
significantly reduced relative risk of developing breast cancer. This findings
support preventative therapeutic intervention of the Gas6-Axl pathway to
combat breast cancer. Using the breast tissue mimetic models which allow us
to study the aging process at the molecular, cell and tissue levels, we hope to
identify entirely new classes of therapeutic targets that will usher in a new
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Figure 23: A cartoon showing archetypical age-related states of
breast tissue. With age, the fat gradually replaces the connective tissue in
the stroma that surrounds the mammary epithelia. Multipotent progenitors
accumulate, luminal cells lose lineage fidelity and acquire the basal traits
of the myoepithelial cells. The proportions of tumor-suppressive and
contractile myoepithelial cells themselves also decreases with age. Reduction of
myoepithelial cells might help explain putative discontinuities in the basement
membrane that are thought to arise with age (LaBarge et al., 2015).
era of low toxicity chemoprevention. The ultimate achievement would be to
identify a therapeutic approach to prevent breast cancers that is as safe as
taking aspirin to ward off heart disease, for instance.
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6 Concluding Remarks
We present an approach for interrogation of human aging that takes
advantage of cultured strains of normal HMEC and engineered
microenvironments to perform cell-based molecular and functional studies,
which are validated by comparison with breast tissues. We identified a
previously unappreciated mammary stem cell marker involved in breast
homeostasis and breast cancer progression. We highlighted a novel hallmark
of aging as a defect in microenvironmental stem cell regulation. Specifically,
insensitivity of progenitors to mechanical cues may explain their
accumulation with age. Finally, we revealed a high-dimensional age-related
phenotypic divergence in the breast tissue that may contribute to the
susceptibility to tumorigenesis and we built a robust age classification model.
Moreover, distinct age-related phenotypic signatures were detectable in
cKit-progenitor cells, considered the cell-of-origin for breast cancers.
Identifying pathways altered with age will enable the identification of entirely




Our results suggest that Axl receptor regulation is important for maintaining
multipotent activity of normal stem/progenitor cells and surface receptor
levels are restricted to rare suprabasal cells. Congruently, Axl expression is
regulated at multiple levels. Axl has been previously identified as a YAP
downstream target (Xu et al., 2011). We have shown that Axl expression
correlated with YAP in MEP in vitro. This regulation of Axl by the Hippo
pathway and its role in basal differentiation transcription program requires
further investigation.
In addition, an in situ biomechanical characterization of mammary gland
sections from women of differing age using Atomic Force Microscopy would
be appreciated in order to compare the local epithelial stiffness with age at
the cellular level.
We can speculate that with age, YAP/TAZ activation might result in a
luminal differentiation with basal traits. This activation may lead to oncogenic
pathway activation and malignancy. Further work is needed to target pathways
altered with age, specifically the YAP/TAZ pathway, in order to assess if a
"rejuvenation" of the older luminal cells would be observed via a decrease in
basal traits. In future, this "rejuvenation" may be tested as a potential breast
cancer prevention treatment.
Finally, we observed a population of cKit progenitors accumulating with
age with a CD133high and CD44low phenotype. Others characterized these
cells as cancer stem cells in luminal breast cancer (Sansone et al., 2016).
These cells are highly suspected for the implication as cells-of-origin for breast
cancers. Further investigation is needed to characterize these cells in vivo, to
understand their role in breast cancer progression, and finally to target them
as a preventive cure.
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SUMMARY
Dysfunctional progenitor and luminal cells with
acquired basal cell properties accumulate during
human mammary epithelial aging for reasons not un-
derstood. Multipotent progenitors from women aged
<30 years were exposed to a physiologically relevant
range of matrix elastic modulus (stiffness). Increased
stiffness causes a differentiation bias towards myoe-
pithelial cells while reducing production of luminal
cells and progenitor maintenance. Lineage represen-
tation in progenitors from women >55 years is unaf-
fected by physiological stiffness changes. Efficient
activation of Hippo pathway transducers YAP and
TAZ is required for the modulus-dependent myoepi-
thelial/basal bias in younger progenitors. In older
progenitors, YAP and TAZ are activated only when
stressed with extraphysiologically stiff matrices,
which bias differentiation towards luminal-like phe-
notypes. In vivo YAP is primarily active in myoepi-
thelia of younger breasts, but localization and activ-
ity increases in luminal cells with age. Thus, aging
phenotypes of mammary epithelia may arise partly
because alterations in Hippo pathway activation
impair microenvironment-directed differentiation and
lineage specificity.
INTRODUCTION
The aging process is often correlated with changes in stem cell
activity with consequences ranging from reduced regenerative
capacity to increased cancer incidence. Human hematopoietic
stem cells accumulate with age (Kuranda et al., 2011; Pang
et al., 2011) and exhibit a differentiation bias toward defective
myeloid lineages (Cho et al., 2008), making individuals more
prone to autoimmune problems and myeloid leukemias (Henry
et al., 2011). In mice, the proportion of mitotic neural stem cells
increases with age, whereas numbers of adult-born neurons
decrease (Stoll et al., 2011). Human hippocampus shows pat-
terns of age-related changes similar to mice that may underlie
age-related cognitive decline (Knoth et al., 2010). Transit ampli-
fying cells, not stem cells, accumulate in epidermis with age and
delay wound healing (Charruyer et al., 2009). Mammary epithe-
lium is maintained by a hierarchy of lineage-biased and multi-
potent progenitor and stem cells (Nguyen et al., 2014; Rios
et al., 2014; Villadsen et al., 2007). In humanmammary gland, dif-
ferentiation-defective cKit-expressing multipotent progenitors
(MPPs) accumulate with age, and proportions of daughter myoe-
pithelial (MEP) and luminal epithelial (LEP) cells shift with age.We
hypothesized that these age-associated changes make aged
breast tissue susceptible to malignant progression (Garbe
et al., 2012). Accumulation of defective stem or progenitor cells
may be a common phenotype among aging tissues, and we
hypothesize that aged MPPs accumulate because they do not
correctly perceive microenvironmental differentiation cues.
The molecular composition of microenvironments impose
specific cell fate decisions in normal and immortal nonmalignant
mammary MPP (LaBarge et al., 2009). Cell culture substrata
tuned to elastic moduli that mimicked normal breast tissue
also biased the differentiation of an immortal nonmalignant
MPP cell line into LEP (Lui et al., 2012). Matrix stiffness is mech-
anistically important in breast cancer progression as well; rigid
breast tissue correlates with high breast cancer risk and drives
malignant phenotypes in breast cancer cell lines (Yu et al.,
2011). The physiological range of elastic modulus in breast likely
plays an instructive role in the differentiation of normal mammary
epithelial progenitors.
Membrane and cytoskeleton proteins sense mechanical
cues and trigger transduction cascades that relay information
throughout the cytoskeleton and to the nucleus. Responses
can include changes in morphology and gene expression (Vogel
and Sheetz, 2006). Sensing matrix elasticity occurs through cell-
cell and cell-extracellular matrix (ECM) interactions mediated by
adherens, integrins, vinculin, focal adhesion kinase (FAK), and
others (Beningo et al., 2001; Bershadsky et al., 2003; Tamada
1926 Cell Reports 7, 1926–1939, June 26, 2014 ª2014 The Authors
Pelissier etal. Age-related dysfunction in mechanotransduction impairs differentiation of human mammary epithelial progenitors
et al., 2004). The actinomyosin network includes RhoA, which
regulates the actin cytoskeleton in the formation of stress fibers
(SFs) and focal adhesions (FAs). Activation of ROCK1/ROCK2
causes increased activity of the motor protein myosin II by phos-
phorylation of the myosin light chain (MLC) and inactivation
of the MLC phosphatase (Ishizaki et al., 1997; Kimura et al.,
1996). YAP and TAZ are Hippo pathway transcriptional coactiva-
tors that are thought to interact with the Rho pathway to trans-
duce mechanical information about the microenvironment to
the nucleus (Halder et al., 2012). As stiffness increases, YAP/
TAZ relocates from cytoplasm into nucleus, where they generate
gene expression patterns that underlie cellular functions like pro-
liferation, migration, epithelial-to-mesenchymal transition, and
differentiation (Dupont et al., 2011; Kanai et al., 2000; Zhao
et al., 2007).
Differentiation of mesenchymal stem cells down neurogenic,
myogenic, or osteogenic pathways was directed by exposure
to a wide range of tissue-relevant elastic moduli, from 100 to
40,000 Pa (Engler et al., 2006). In comparison, mammary
MPP differentiation should be responsive to a much narrower
range of modulus relevant to normal and malignant breast
(1004,000 Pa; Paszek et al., 2005). The impact of aging on
modulus-directed differentiation is unknown. Addressing these
issues required a culture-based platform for functional analyses
of primary normal human mammary MPP frommany individuals.
Here, we used such an approach to demonstrate that differenti-
ation patterns of MPP from women aged <30 years cultured on
tunable 2D and 3D substrata were exquisitely responsive to a
physiologically relevant range of elastic modulus in a YAP/
TAZ-dependent manner, whereas MPP from women >55 years
were relatively unresponsive to changes in rigidity due to ineffi-
cient activation of the Hippo pathway transducers.
RESULTS
Aging Alters Modulus-Dependent Differentiation
To test whether microenvironment rigidity directed differentia-
tion in MPP, we enriched receptor tyrosine kinase cKit-express-
ing (cKit+) human mammary epithelial cells (HMECs) by flow
cytometry (fluorescence-activated cell sorting [FACS]) from
fourth passage primary prestasis HMEC (strains) derived from
five women aged <30 years and five from women >55 years
(Figure S1; Table S1). Prestasis HMEC strains are normal and
not treated with any immortalizing agents, have finite lifespans,
and we previously demonstrated that they retain molecular,
biochemical, and functional properties consistent with chrono-
logical aging in vivo (Garbe et al., 2012). The cKit+ MPP were
cultured for 48 hr on type 1 collagen-coated polyacrylamide
(PA) gels. The Young’s elastic modulus (E[Pa]scals) of the PA
gels was tuned from 200 Pa to 2,350 Pa. The lineage of each
daughter cell was confirmed by immunofluorescence (IF) of
intermediate filament proteins keratin (K)14 and K19, CD227
(sialomucin-1), and CD10 (Calla; Figures 1A, 1B, 1E, and 1F).
Computer image analysis identified the different lineages; LEP
are CD227+/CD10/K14/K19+, MEP are CD227/CD10+/
K14+/K19, and K14+K19+ expression is consistent with MPP
states (Villadsen et al., 2007). cKit+ MPP from women <30 years
generated proportionately more LEP on soft substrata, but gen-
eration of MEP increased with higher E (Figures 1C, 1C’, 1G, and
S2A). cKit+ MPP from women >55 years did not generate
different lineage proportions in response to changes in E (Figures
1D, 1D’, 1H, and S2B). Primary first passage cKit+ MPP from
three women <30 years, embedded in tunable 3D hydrogels
with some type 1 collagen for 7 days (Figure S3A; Ananthanar-
ayanan et al., 2011), gave rise to more LEP at 120 Pa versus
more MEP at 3,800 Pa (Figures 1K, 1M, 1M’, and S3B). In
contrast, cKit+ MPP from three women >55 years did not display
modulus-dependent differentiation patterns (Figures 1L, 1N,
1N’, and S3C). The proportion of K14+/K19+ MPP decreased
with elastic modulus on 2D PA gels and in 3D gels <30 years
HMEC (Figures S4A–S4C), but no change in proportions of
MPP was observed in >55 years HMEC (Figures S4B, S4D,
and S4F). These results suggested that differentiation was
modulus dependent in younger MPP and that this response
was lost with age.
To test if changes in lineage proportions were due to lineage-
biased proliferation, incorporation of 5-ethynyl-20-deoxyuridine
(EdU) into DNA was measured as a proxy for proliferation. All
lineages derived after 48 hr from cKit+ MPP on PA gels exhibited
similar proportions of EdU incorporation (EdU+), irrespective of
substrate rigidity or age (Figure 1I). In contrast, EdU incorpora-
tion in unsorted HMEC strains, which are primarily composed
of more mature LEP and MEP, revealed age- and lineage-
specific replicative behaviors. Proportions of EdU+ MEP from
<30 years HMEC significantly increased with greater E whereas
EdU+ LEP trended downward (Figure 1J). Unsorted HMEC
from women >55 years exhibited neither lineage- nor modulus-
dependent proliferation (Figure 1J), underscoring the lack of
mechanoresponse with age. Thus, changes in lineage propor-
tions exhibited by <30 years MPP after 48 hr were likely due to
modulus-dependent differentiation, and only after the lineages
matured in <30 years HMEC strains, did they show evidence of
modulus-dependent proliferation.
Mechanosensing Functions Were Unaltered by Age
To determine whether mechanosensing was age dependent,
F-actin SF formation and FA assembly activities were measured
in cKit+ MPP from three <30 years and three >55 years strains.
Irrespective of age, SF formation increased with greater E (Fig-
ure 2A). Homogeneity measurements were used to quantify for-
mation of the F-actin cables (Haralick et al., 1973; Pantic et al.,
2012); SF homogeneity was inversely proportional to E in both
age groups, which showed similar slopes (Figures 2B and 2C).
Progenitors fromboth age groupswere stained for pFAK and vin-
culin, which colocalize at FA.More FA assemblieswere observed
with increased Eat the interfaces ofMPPand gels, and FA forma-
tion was not impaired with age (Figures 2D and 2E). FA homoge-
neity was inversely proportional to E with comparable slopes in
both age groups (Figures 2F and 2G). Thus, similar SF and FA
phenotypeswereobservedboth in younger andolder cKit+MPP.
Extracellular signal-regulated kinase (ERK) is phosphorylated
in response to increased elastic modulus in some adherent cell
lines (Provenzano et al., 2009), and because it is a key effector
of serum responses, changes in its modulation could cause
pleiotropic cellular responses. Both young and old cKit+ MPP
exhibited a low level of ERK phosphorylation on 200 Pa PA
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Figure 1. Aging Alters Differentiation Patterns in Response to Matrix Stiffness
(A and B) Representative IF images of progenitors from young (240L; 19 years) and (B) an older (122L; 66 years) strains stained for K19 (green), K14 (red), and DAPI
(blue) after 48 hr of culture on PA gels with increasing elastic modulus (E[Pa]). Bars represent 100 mm.
(C and D) Histograms represent log2-transformed ratios of K14 to K19 protein expression in single cells on 2D PA gels with increasing stiffness; histograms are
heat mapped to indicate cells with the phenotypes of K14/K19+ LEPs (green), K14+/K19+ progenitors (yellow), and K14+/K19 MEPs (red).
(C’ and D’) Corresponding linear regression plots of LEP and MEP proportions as a function of modulus are shown for (C’) women <30 years (LEP: p = 0.0429,
r2 = 0.2086; MEP: p = 0.0475, r2 = 0.2009, n = 5) and (D’) women >55 years (LEP: p = 0.4812, r2 = 0.0296; MEP: p = 0.5138, r2 = 0.0240, n = 5). Regressions are
fold change of lineage proportions compared to cKit+ on 200 Pa condition ± SEM.
(E and F) Representative IF images of progenitors from (E) young (240L; 19 years) and (F) older (122L; 66 years) strains stained for CD227 (green), CD10 (red), and
DAPI (blue) after 48 hr of culture on PA gels with increasing elastic modulus. Bars represent 20 mm.
(G and H) Linear regression of fold change of LEP (CD227+/CD10) and MEP (CD227/CD10+) proportions as function of elastic modulus in (G) women <30
years (LEP: p = 0.0080, r2 = 0.5219; MEP: p = 0.0198, r2 = 0.4340, n = 3) and (H) women >55 years (LEP: p = 0.4689, r2 = 0.0536; MEP: p = 0.1937, r2 = 0.5219,
n = 3). Linear regressions are of fold change of lineage proportions normal to 200 Pa condition ± SEM.
(I and J) Percentage of cells incorporating EdU as function of lineages and stiffness in (I) cKit+ HMEC and (J) unsorted HMEC (MEP from women <30 years linear
regression, p = 0.0270, r2 = 0.9467; LEP from women <30 years t test 200 Pa versus 2,350 Pa, p = 0.0153, n = 5). Data are means ± SEM.
(K and L) Representative IF of K19 (green), K14 (red), andDAPI (blue) of passage 1 cKit+ HMEC from a 19-year-old and a 65-year-oldwoman after 7 days of culture
encapsulated in 3D hyaluronic acid (HA) gels. Bars represent 20 mm.
(legend continued on next page)
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gels but increased up to 15-fold on 2,350 Pa PA gels (Figures 2H
and 2I). Differences in pERK were not significant between age
groups, and mitogen-activated protein kinase (MAPK) inhibitor
PD98059 prevented ERK phosphorylation. By these measures,
modulus-dependent activity in serum response was indepen-
dent of age.
If mechanosensing was unaffected by aging, then perturba-
tions of actinomyosin regulators that are known to alter FA
or SF formation should elicit parallel phenotypes in young and
old MPP. Independent of age, we observed that inhibitors of
ROCK1/ROCK2 (Y27632) and MLC kinase (ML-7) tended to
disrupt SF on 2,350 Pa substrata and showed little effect at
200 Pa, whereas the MLC phosphatase inhibitor calyculin A
(calA) caused SF formation at 200 Pa (Figures 3A and 3B). Pat-
terns of changes in F-actin homogeneity were parallel in both
age groups (Figures 3C and 3D). Y27632 and ML-7 disrupted
the FA assemblies on 2,350 Pa substrata, whereas calA pro-
moted FA assembly on 200 Pa substrata (Figures 3E and 3F)
and measurements of FA homogeneity showed parallel changes
in both age groups (Figures 3G and 3H). Mechanosensing of
substrata in the physiologically relevant range was age indepen-
dent, evaluated by these measures, and thus was unlikely to ac-
count for age-dependent differences in mechanically directed
differentiation.
Analysis of the effects of actinomyosin network modulation on
differentiation in three young and three old cKit+ MPP revealed
surprising age-dependent responses. FA and SF in cells treated
with Y27632 andML-7 on 2,350 Pa gels were similar to untreated
cells on 200 Pa gels, whereas calA increased the SF and FA as if
cells were on stiffer substrata. Thus, SF and FA phenotypes
were pharmacologically manipulated irrespective of the actual
substrate E. Younger cKit+ MPP treated with Y27632 or ML-7
significantly increased proportions of K19+ LEP compared to
DMSO-treated cells on 2,350 Pa gels. In contrast, older MPP
were unaffected by Y27632 or ML-7 treatment (Figure S5). Inter-
estingly, calA increased MEP generation from young MPP but
caused older MPP to give rise to significantly more LEP. No
changes in proportion were observed on 200 Pa gels, suggesting
that addition of calA was insufficient to trigger cell differentiation
on such a soft substrata. Older progenitors did not respond
to chemically decreased perception of stiffness, but they re-
sponded to artificially higher stiffness oppositely to that of young
progenitors, suggesting that age-dependent transcriptional pro-
grams were operative.
Aging Alters the Ability of YAP and TAZ to Transduce
Mechanical Information to the Nucleus
We next determined whether the mechanotransducive tran-
scription factors YAP and TAZ were involved in modulus-
dependent differentiation. IF staining of YAP and TAZ in cKit+
MPP from three HMEC strains <30 years exhibited increased
YAP/TAZ nuclear translocation as PA gel E increased from
200 to 2,350 Pa (Figures 4A and 4B). However, significant nu-
clear translocation of YAP/TAZ was not observed in older pro-
genitors in the same range (Figures 4C and 4D). The ability to
activate YAP/TAZ by changes in substrate E was age
dependent.
To determine the extent to which YAP/TAZ was unresponsive
to changes in E in older progenitors, we evaluated their activation
in response to extraphysiological stiffness. cKit+MPP from three
young and three old strains were cultured on type 1 collagen-
coated glass (>3 GigaPa) or 200 Pa gels. YAP/TAZ translocated
to the nucleus in young cKit+ MPP on glass (Figures 4A and 4B),
gave rise to fewer LEP (Figure 4E), and those LEP incorporated
less EdU on glass compared to 200 Pa gels (Figure 4F). In older
cKit+ MPP on glass, YAP/TAZ was nuclear (Figures 4C and 4D),
but cells gave rise to more LEP (Figure 4G), which incorporated
more EdU on glass than on 200 Pa gels (Figure 4H). Both calA
treatment and culture on extraphysiologically rigid substrata eli-
cited more LEP differentiation in older MPP, which was the
opposite of younger MPP. Thus, the Hippo pathway mechanor-
esponse in older progenitors was shifted to an extraphysiologi-
cal ‘‘trigger point’’.
To determine if YAP and TAZ were required for modulus-
dependent differentiation, both in the physiological and ex-
traphysiological ranges, cKit+ MPP were transfected with small
interfering RNAs (siRNAs), siYAP or siTAZ, which achieved
>70% knockdown of the respective mRNAs (Figure 4K). K14
and K19 proteins were measured by IF in each cell after 48 hr
on PA gels. Younger MPP harboring either siYAP or siTAZ were
unable to give rise to more MEP on 2,350 Pa PA gels and glass
substrata compared to controls (Figure 4I). In older MPP, siYAP
and siTAZhad no effect at 200Pa or 2,350Pa, but they prevented
the generation of more LEP on glass (Figure 4J). Thus, YAP and
TAZ were required for modulus-dependent differentiation in
progenitors irrespective of age.
YAP Localization Changes with Age In Vivo
That YAP and TAZ activity correlated with a bias toward MEP
in younger women prompted us to evaluate normal breast tis-
sue sections from reduction mammoplasty. K14, K19, and
YAP were evaluated by IF in sections from four women aged
34 years, 40 years, 50 years, and 54 years (Figure 5A). Multi-
ple fields from each section were analyzed to account for het-
erogeneity, and marker-based watershed cell segmentation
identified levels of YAP in nuclear and cytoplasmic domains
of MEP, LEP, and K14+/K19+ putative MPP. YAP staining
was localized mainly to the nuclei of MEP and MPP in the
34 years and 40 years glands (Figure 5B). In the 34 years
gland, we also observed a number of occurrences of K14+/
K19 cells that we assumed were LEP based on their luminal
location. Upon measuring the YAP signal intensity, it was
determined that the K14+ cells always correlated with higher
YAP expression (Figure 5C). In contrast to younger epithelia,
the 50 years and 54 years glands exhibited no inequality in
YAP localization between the different lineages (Figure 5B),
(M and N) Histograms represent log2-transformed ratios of K14 to K19 protein expression in single cells in 3D HA gels; histograms are heat mapped to indicate
cells with the phenotypes of K14/K19+ LEPs (green), K14+/K19+ progenitors (yellow), and K14+/K19 MEPs (red).
(M’ and N’) Fold changes of lineage proportions normal to 120 Pa condition (chi-square test women <30 years, p = 0.0146; women >55 years, p = 0.9113).
See also Figures S2, S3, and S4 and Table S2.
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and qualitatively, the even-appearing distribution of YAP in the
nuclei and cytoplasm of the LEP and MEP in older women
was reminiscent of YAP staining in >55 years HMEC (Fig-
ure 5C). YAP distribution in vivo was age dependent consis-
tent with our findings in primary cultures. Overall, the data
suggest that YAP activity is associated with MEP/basal phe-
notypes, even in the case of LEP in older women that acquire
some traits of MEP. That impression was strengthened by our
analysis of breast cancer data from The Cancer Genome Atlas
data (Cancer Genome Atlas, 2012), which showed that YAP/
TAZ mRNA expression negatively correlated with levels of
LEP-related proteins and mRNAs and positively correlated
with markers of MEP and with YAP/TAZ target genes (Figures
S6A and S6B).
Figure 2. Mechanosensing Apparatuses Function Independently of Age to Generate Actin Stress Fibers, Focal Adhesions, and ERK
Activation
(A) Representative IF images of F-actin (green) in cKit+ HMEC from a young strain (240L; 19 years) and an older strain (122L; 66 years) on PA gels of increasing
stiffness.
(B and C) Quantification of F-actin homogeneity using feature detection (B, p < 0.0001 and r2 = 0.8297, slope =6.8053 105 ± 9.7493 106, n = 3; C, p < 0.001
and r2 = 0.6853, slope = 8.454 3 105 ± 1.811 3 105, n = 3). The slopes are not significantly different (p = 0.5699).
(D and E) Representative IF images of pFAK (red) and vinculin (green), which overlapped (yellow), from confocal microscopy are shown in cKit+ HMEC from (D) a
young strain (240L; 19 years) and (E) an older strain (122L; 66 years). Cells are shown at the substrata interface. Bars represent 20 mm.
(F and G) Quantification of vinculin and pFAK homogeneity (F, p < 0.001 and r2 = 0.7456, slope = 6.512 3 105 ± 1.203 3 105, n = 3; G, p < 0.001 and
r2 = 0.7581, slope = 6.356 3 105 ± 1.136 3 105, n = 3). The slopes are not significantly different (p = 0.8124). Data are means ± SEM.
(H and I) Ratio of pERK positive to ERK positive cell number in cKit+ HMEC from <30 years (n = 3) and >55 years (n = 3) strains on 200 Pa and 2,350 Pa.
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Levels of HippoPathwayComponentsChangedwithAge
To better understand why the trigger point for YAP/TAZ was
increased in older MPP, we determined whether Hippo pathway
components showed age-dependent expression patterns.
Mst1/Mst2, Lats2, and angiomotins (AMOT) phosphorylate
and sequester YAP/TAZ in the cytoplasm, which would prevent
YAP/TAZ from associating with DNA-binding cofactors TEAD1–
TEAD4 and transcribing target genes, like connective tissue
growth factor (CTGF) (Zhao et al., 2007, 2011). Analysis
with quantitative real-time PCR (qRT-PCR) revealed that, in
almost all cases, MST1/MST2, LATS2, AMOT, AMOTL1,
TEAD1–TEAD4, and CTGF were significantly correlated be-
tween women <30 years and women >55 years on 200 Pa
(Figure 6A; p = 0.0110; R = 0.7283) and 2,350 Pa (Figure 6B;
Figure 3. Perturbations of Actinomyosin Regulators Elicit Parallel Phenotypes in Progenitors from Young and Old Age Groups
(A and B) Representative IF images of F-actin with phalloidin (green) in cKit+ HMEC from (A) a young strain (240L; 19 years) and (B) an older strain (122L; 66 years).
(C and D) Quantification of F-actin homogeneity in (C) younger cKit+ (n = 3) and (D) older cKit+ (n = 3).
(E and F)Merged images of IF of pFAK (red) and vinculin (green), overlap is (yellow), in cKit+ HMEC from (E) the young strain and (F) the older strain. Bars represent
20 mm.
(G and H) Quantification of vinculin and pFAK homogeneity in (G) young cKit+ (n = 3) and (H) older cKit (n = 3).
See also Figure S5.
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Figure 4. YAP and TAZ Activation Are Altered during Aging
(A and C) Representative IF images of TAZ, YAP (green), and DAPI (red) in cKit+ HMEC from (A) a young strain (240L; 19 years) and (C) an older strain (353P; 72
years). Bars represent 20 mm.
(B and D) Bar plots represent the distribution of YAP and TAZ (N, predominantly in the nucleus; N/C, equally distributed; C, predominantly in the cytoplasm) from
over 100 cells/strain in (B) younger (n = 3) and (D) older (n = 3) strains.
(E and G) K19+LEP and K14+MEP proportions derived from cKit+ HMEC from (E) younger (n = 5) and (G) older (n = 5) women. Data are fold change of cell
proportions compared to glass control ± SEM.
(F and H) Percentage of EdU+ LEP and MEP derived from cKit+ HMEC from (F) younger (n = 5) and (H) older (n = 5) women. Data are means ± SEM.
(I and J) K19+LEP and K14+MEP proportions derived from cKit+ HMEC from (I) younger and (J) older strains transfected with YAP or TAZ siRNA.
(K) Bar graphs of YAP and TAZ transcript knockdown following siRNA treatment and NSC scrambled control siRNA.
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p = 0.0083; R = 0.7464) gels. On glass, the correlation was less
pronounced (Figure 6C; p = 0.0543; R = 0.5934). Because differ-
ences in Hippo gene expression were not strikingly age depen-
dent in physiological conditions, we examined protein levels of
MST1 and MST2. MST1 levels from three women <30 years
and three women >55 years were not significantly different (Fig-
ures 6D–6G). MST2 protein levels were 3-fold greater in MPP
from women >55 years compared to <30 years on 2,350 Pa
gels (Figure 6E). Thus, it is tempting to speculate that
age-dependent stoichiometry of Hippo pathway regulators
can lead to insensitivity to mechanical cues and activation of
YAP/TAZ.
Immortalization of Aged HMECs Restored
Responsiveness to Physiological Stiffness
Cellular responses tomechanical stimuli are often examinedwith
mesenchymal stem cells or immortal malignant and nonmalig-
nant cell lines. Whereas immortal cell lines tend to proliferate
more on stiffer substrata, we showed that normal <30 years
HMEC exhibited lineage-dependent responses and that
Figure 5. YAP Localization Changes with Age In Vivo
(A) Representative IF images of K14 (red), K19 (green), YAP (white), and DAPI (blue) in human mammary breast sections from four women (aged 34 years, 40
years, 50 years, and 54 years). Bars represent 20 mm.
(B) Bar plots represent the distribution of YAP (N, predominantly in the nucleus; N/C, equally distributed; C, predominantly in the cytoplasm) from over 100 cells/
woman.
(C) YAP signal isolation from the immunofluorescence of K14 (red), K19 (green), YAP (white), andDAPI (blue) from the 34-year-old woman. Arrows identify luminal-
positioned K14+/K19low/ cells. The line graph shows mean pixel intensities from the lumen to the basal side of the structure in ten different examples of K14+
luminal cells.
See also Figure S6.
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<55 years HMECwere nonresponsive to a physiological range of
E (Figure 1). To better understand the differences between the
normal and immortal nonmalignant states as a function of age,
we examined immortal nonmalignant cell lines derived from
two young and two old primary HMEC strains by targeted inac-
tivation of senescence barriers combined with unknown
genomic errors (Stampfer et al., 2013). The cell lines, 240LMY
(19 years), 184Fp16s (21 years), 122LMY (66 years), and
805Pp16s (91 years; Figure S7) were cultured atop PA gels tuned
from 200 to 2,350 Pa. cKit+ MPP from 240LMY and 184Fp16s
cell lines gave rise to more K14+ MEP than LEP on glass
compared to 200 Pa PA gels (Figure 7A). cKit+ MPP from
122LMY and 805Pp16s gave rise to more K19+ LEP than MEP
on glass compared to 200 Pa PA gels (Figure 7B). Independent
of age, all lineages of the immortal cell lines incorporated more
EdU as rigidity increased (Figures 7C–7F). YAP/TAZ nuclear
translocation was detected both in <30 years and >55 years
Figure 6. Age-Dependent Patterns of Hippo
Pathway Components
(A–C) Correlation of gene expression between
cKit+ HMEC from younger (n = 3) and older (n = 3)
strains after 24 hr on (A) 200 Pa, (B) 2,350 Pa PA
gels, and (C) >3 GPa substrate. Data are normal-
ized to GAPDH expression.
(D–F)Western blot densitometric analysis of MST1
and MST2 from cKit+ HMEC from younger (n = 3)
and older (n = 3) strains after 24 hr on (D) 200 Pa,
(E) 2,350 Pa PA gels, and (F) >3 GPa substrate.
Data are normalized to beta-actin protein content
and are mean ± SEM.
(G) Representative western blot with quantification
from a young (240L; 19 years) and an older strain
(122L; 66 years).
cell lines on PA gels from 200 to
2,350 Pa (Figures 7G–7N). Thus, immor-
talization of older HMEC restored sensi-
tivity of the Hippo pathway to the physio-
logical stiffness range, albeit abnormally
because proliferation was no longer
lineage-dependent. The propensity of
immortal cell lines to generate more
MEP or LEP on extraphysiological sub-
strata was consistent with the chronolog-
ical age of the HMEC, suggesting that
the intrinsic age-related changes were
stable.
DISCUSSION
Matrix rigidity is a determinant of mam-
mary epithelial progenitor differentiation.
Exposure of progenitors to mechanically
tuned culture substrata revealed two
fundamental changes that arise in MPP
with age: (1) the mechanical trigger point
for activation of YAP/TAZ increases, and
(2) the YAP/TAZ-dependent differentia-
tion programs become distinct. Culture of MPP from <30-
year-old women in the most compliant 2D or 3D conditions
(100–200 Pa) enhanced LEP differentiation, whereas stiffer sub-
strata (2,300–3,800 Pa) favored MEP production. Older progen-
itors stochastically differentiated when exposed to a physiolog-
ically relevant elastic modulus range. Our results document the
role of YAP/TAZ transcription factors as drivers of modulus-
dependent differentiation in human mammary epithelial MPP
and suggest that YAP/TAZ activity favors differentiation into
MEP and other basal cell types. The basal cell types are not
exclusive toMEP andmay include LEP that express K14 or other
basal-associated markers, which we and others have observed
(Santagata et al., 2014). Older MPP needed to be stressed with
extraphysiologically stiff substrata to reveal their YAP/TAZ-
dependent bias toward LEP, which was consistent with our
observation in vivo that YAP tended to be located in LEP with
increased age. In younger women, YAP was in the nuclei of
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K14-expressing MEP, as well as the apical snouts of LEP. We
previously demonstrated that postmenopausal LEP tend to ex-
press some K14, as well as other markers associated with
MEP, and these new data suggest that age-dependent changes
in YAP/TAZ activity may underlie that phenotype of aging.
Radiographic density of breast tissue tends to decrease with
age suggesting that the mechanical environment is also altered
(Benz, 2008), but mechanical forces do not exclusively govern
YAP/TAZ regulation. Our experimental approach took advan-
tage of tuned mechanical perturbations of matrix to functionally
Figure 7. Immortalization Restores Responsiveness to Physiological Stiffness in Older HMEC
(A and B) K19+LEP and K14+MEP proportions derived from immortalized cell lines from (A) younger (p = 0.0111; n = 2 individuals in triplicate) and (B) older
(p = 0.0056; n = 2 individuals in triplicate) women. Data are fold change of cell proportions compared to glass control ± SEM.
(C–F) Percentage of cells from immortalized cell lines derived from primary strains (240LMY at passage 25, 184Fp16s at passage 31, 122LMY at passage 19, and
805Pp16s at passage 29) incorporating EdU as a function of lineage, as defined by K14 and K19 expression, and stiffness.
(G–N) Bar plots represent the distribution of YAP and TAZ (N, predominantly in the nucleus; N/C, equally distributed; C, predominantly in the cytoplasm) from over
100 cells/lineage in immortalized cell lines. By comparison to the other cell lines, 184F derivatives are known to be mainly basal at the expense of LEP and
progenitor phenotypes.
See also Figure S7.
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probe the HMEC, but more broadly these results revealed that
aging fundamentally alters Hippo pathway regulation. The role
of cell-cell contact in Hippo pathway regulation should be further
investigated in the context of chronological age. Both Wnt/beta-
catenin and NF2 are known to regulate YAP/TAZ in vivo (Cock-
burn et al., 2013; Imajo et al., 2012), and changes to both path-
ways have been implicated in different age-related cancers
(Evans et al., 2005; Seidler et al., 2004). Little is known about
whether YAP/TAZ play a role in other phenotypes of aging. Defi-
ciency in C. elegans yap-1 resulted in overall healthier aging
relative to controls (Iwasa et al., 2013). Disrupted Hippo
signaling in human and mouse ovarian follicles, which caused
YAP activation, promoted growth and oocyte maturation, which
are processes typically defective with age (Kawamura et al.,
2013). Indirect evidence suggests mesenchymal stem cells
also have dampened modulus-dependent differentiation re-
sponses with age. Bone is magnitudes stiffer than adipose
tissue and the osteogenic potential of mesenchymal stem cells
decreases and a bias toward adipogenesis increases with age
(Moerman et al., 2004), but the role of Hippo is unclear.
Accumulation of MPP with age may be attributed to inefficient
transduction of differentiation cues through the Hippo pathway.
At low cell density, decreased Lats2 activity dependent on
SF formation causes YAP/TAZ to translocate to the nucleus
(Wada et al., 2011), but <30 years and >55 years MPP formed
SF and FA comparably in response to changes in matrix stiff-
ness. Thus, we explored the potential for stoichiometric imbal-
ances in Hippo kinases with age that could dampen activation
of YAP/TAZ. In our hands, MST2 protein was higher in >55 years
MPP, suggestive of a damping mechanism. The Hippo pathway
is implicated in differentiation of different progenitors into
adipose, breast, muscle, and bone tissues, representing a
wide range of elastic modulus and predicting a marvelously
adaptable molecular rheostat. Each of these tissues differs in
their matrix composition as well as physical attributes, and there
is a reasonable expectation that combinations of ECM and
growth factors tune Hippo pathway activity. Further study of
microenvironment regulation of the Hippo pathway may identify
components of the activation rheostat and reveal the basis for its
age-related dampening.
Changes to the mechanical microenvironment affect multiple
cell types in breast. High breast stiffness and density are corre-
latedwith increased risk and cancer progression (Yu et al., 2011).
Increased stiffness also can induce adipocyte progenitors to
differentiate into fibroblasts, which can positively feedback to
further increase tissue stiffness (Chandler et al., 2012). MPP
from women <30 years responded to increasingly rigid matrices
by increased production of MEP, which are thought to be tumor
suppressive (Gudjonsson et al., 2002; Hu et al., 2008), and pro-
portionately decreased numbers of cells with the MPP pheno-
type, which are hypothesized to be breast cancer cells of origin
(Lim et al., 2009), suggestive of a protective mechanism from tu-
mor progression in younger epithelia. However, this putative pro-
tective mechanism falters with age, as demonstrated when aged
HMEC were essentially unresponsive to physiological changes
in matrix rigidity.
We speculate that the prevalence of luminal subtype breast
cancers in postmenopausal women may be the result of age-
acquired epigenetic states. When older MPP were exposed to
extraphysiologically stiff substrata, they exhibited LEP-biased
differentiation—the exact opposite of the younger progenitors.
Age-dependent differentiation patterns were preserved in
immortal young and old HMEC, but the mechanotransducive
mechanism was notably rejuvenated in older immortal cells,
enabling them to proliferate increasingly as matrix modulus ap-
proached that of a tumor. YAP/TAZ were required for shifting
production in favor of MEP in younger and LEP in older MPP
on the stiffer surfaces. We hypothesize that the distinct differen-
tiation responses of younger and older MPP reflect age-depen-
dent epigenetic landscapes. Indeed, normal HMEC exhibit
age-dependent gene expression patterns consistent with the
concept of age-dependent epigenetic states (Garbe et al.,
2012). A precedent was set in hematopoietic stem cells where
DNA and histone modifications were shown to correlate with
age-related functional phenotypes (Chambers et al., 2007). Stro-
mal feedback loops can result in formation of stiffened regions; if
such regions already contained an accumulation of aged pro-
genitor cells carrying errors predisposing them to immortality,
they could create an environment that promotes development
of age-related luminal subtype breast tumors.
Finally, it is important to be able to empirically examine the
cell and molecular consequences of aging in normal human
epithelia because most carcinomas are age-related. Wild-type
mice are typically resistant to cancers, murine models of breast
cancer do not completely model the steps of cancer progres-
sion in HMEC (Stampfer et al., 2013), and most inbred strains
exhibit tumor incidence curves consistent with sporadic tumor
genesis; thus, mice may not be an optimal model for studying
the genesis of age-related breast cancers. Here, we present
an approach for interrogation of human aging that takes advan-
tage of cultured strains of normal HMEC and engineered micro-
environments to perform cell-based molecular and functional
studies, which are validated by comparison with breast tissues.
Most studies that have drawn conclusions from breast cancer
cell lines or mouse studies have used three methods to estab-
lish relevance of their results to human in vivo: an experiment
with primary HMEC that recapitulates the main findings, exam-
ination of tissue sections for in vivo evidence that correlates with
the findings, and correlation with large gene/protein expression
data sets derived from patient samples. We have followed these
three conventions. We find it striking that many of the molecular
and biochemical phenotypes of aging persist in our early
passage strains in spite of the imperfect microenvironment,
which reinforces our impression that age-associated epigenetic
changes are stabilizing those phenotypes. However, limitations
and challenges are intrinsic to every experimental system. Early
pregnancy has a detectable protective effect against breast
cancer, and the balance of epithelial lineages and gene expres-
sion patterns in mice and humans are affected by parity (Choud-
hury et al., 2013). Our current strain collection is not annotated
for parity information, and focused studies should be conducted
to determine how parity modifies the aging phenotype in breast.
There is an impressive level of heterogeneity among human
mammary epithelia as was beautifully shown by detailed exam-
inations of luminal lineages (Santagata et al., 2014; Shehata
et al., 2012). Our method for establishing primary strains
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encompasses a significant amount of the total heterogeneity in
given surgical specimen, and low stress culture conditions
maintain MPP activity in early passages (Labarge et al., 2013).
We also addressed this issue of heterogeneity and potential
for interindividual variation by using strains established from
17 different women, with any given experiment comparing thou-
sands of independent measurements from groups comprised of
three to five strains each. We find repeatedly that the functional,
molecular, and biochemical phenotypes often differ between
the pre- and postmenopausal age groups, underscoring the
importance of chronological age as an experimental variable.
EXPERIMENTAL PROCEDURES
Cell Culture
All cell culturewas inM87Amediumwith cholera toxin at 0.5 ng/ml andoxytocin
(X) at 0.1 nM (Bachem; Garbe et al., 2009). Primary HMEC strains were gener-
ated and maintained as described (Labarge et al., 2013); all tissues were ob-
tained with proper oversight from the Lawrence Berkeley National Laboratory
institutional review board. Modulus-dependent effects were measured in sub-
confluent cultures. Table S1 shows the strains used for each experiment.
Reagents
Cells were treated with Y27632 (10 mM; Sigma), ML-7 (10mM; Sigma), or
calyculin A (2 nM; Calbiochem) 2 hr after adhesion. Cells were treated
with PD98059 (50 mM; Cell Signaling Technology) 24 hr after adhesion. Cells
were transfected with YAPsi, WWTR1 (TAZsi), or nontargeting control siRNA
SMARTpools (Dharmacon/Thermo) plus a fluorescein isothiocyanate (FITC)
label with DharmaFECT reagent according to manufacturer 24 hr prior to
FACS enrichment.
Flow Cytometry
Anti-CD227-FITC (BD;cloneHMPV;1:50), anti-CD10-phycoerythrin (BioLegend;
clone HI10a; 1:100), and anti-CD117-antigen-presenting cell (BioLegend; clone
104D2; 1:50) were added to cells in media for 25 min on ice, washed in PBS,
and sorted with a FACSVantage DIVA (Becton Dickinson).
PA Gels
PA gels were made on circular, 12 mm coverslips etched in 0.1 M NaOH
following an adapted protocol (Tse and Engler, 2010). Sulfo-SANPAH
(0.4 mM) was activated by UV light, and then collagen was added
(0.1 mg/ml in 50 mM HEPES; Sigma). ddH2O washed gels were placed in
polyHema-treated (0.133 ml at 12 mg/ml in 95% EtOH) 24-well plates. Gel
modulus was confirmed with atomic force microscopy.
Immunofluorescence
HMEC were fixed in methanol:acetone (1:1) at20C for 15 min, blocked with
PBS, 5% normal goat serum, 0.1% Triton X-100, and incubated with anti-K14
(1:1,000; Covance; polyclonal rabbit) and anti-K19 (1:20; Developmental
Studies Hybridoma Bank; clone Troma-III) overnight at 4C and then visualized
with fluorescent secondary antibodies (Invitrogen) incubated for 2 hr at room
temperature. EdU was added to culture media 4 hr prior to fixing cells and
was imaged with Alexa 647 click reagents (Invitrogen). Paraformaldehyde
(2.5%) was used for fixation for phalloidin (1:50; Invitrogen), anti-pFAK
(1:1,000; Invitrogen; monoclonal antibody [mAb]), anti-vinculin (1:400; Sigma;
mAb), anti-YAP (1:100; Santa Cruz Biotechnology; SC-15407), anti-TAZ
(1:200; CST; polyclonal), phospho-p44/42 MAPK (Erk1/Erk2; 1:100; CST
mAb), and p44/42 MAPK (Erk1/Erk2; 1:100; CST mAb). Paraformaldehyde
(1.6%) was used for fixation for anti-CD227 (1:200; Abcam; polyclonal) and
anti-CD10 (1:100; BD Biosciences; clone HI10a). Paraffin-embedded sections
were deparaffinized and antigen retrieved (Vector Laboratories) and stained
with primary antibodies to K14 (1:1,000; Covance; PRB-155P; visualized
with A647 Zenon probes from Invitrogen), K19 (1:100; Abcam; AAH07628)
and YAP (1:100; Santa Cruz; SC-15407). Cells were imaged with LSM710
confocal microscope (Carl Zeiss). Image analyses were conducted using a
modified watershed method in Matlab software (Mathworks); see Supple-
mental Information for detailed code.
Real-Time PCR
Total RNA was purified with Trizol (Invitrogen) followed by RNeasy prep
(QIAGEN). cDNA was synthesized with SuperScript III RT (Invitrogen). Tran-
scripts levels were measured by qRT-PCR using iTaq SYBR Green Supermix
(BioRad) and LightCycler480 (Roche). Primer sequences are in the Supple-
mental Information.
Generation of Immortal Cell Lines
Finite lifespan HMEC from specimens 184, 240L, 122L, and 805P were grown
in M87A. Retroviral vectors: the p16 small hairpin RNA was in MSCV vector,
and c-Myc was in pBabe–hygro (BH2) or LXSN vector. Retroviral stocks
were generated from supernatants collected in M87A medium. Strains 240L,
122L, and 805P at passage 3 or and 184 at passage 4 were transduced with
MSCV-p16sh or MSCV control and selected with puromycin. At the next pas-
sage, after puromycin selection, the p16sh-transduced cells were transduced
with c-Myc pBabe–hygro (c-myc LXSN for 184) and selected with hygromycin.
Vector-only control prestasis cells entered stasis at passages 12–15, whereas
the immortalized lines continued to grow.
Western Blot
The following antibodies were used: MST1 CST no. 3682 rabbit 1:1,000, MST2
CST no. 3952 rabbit 1:1,000, beta-actin Abcam no. 8227 rabbit 1:500, and
visualized with goat anti-rabbit immunoglobulin G (H + L)-horseradish peroxi-
dase conjugate no. 170-6515 1:10,000.
TCGA Database
All data were obtained from the The Cancer Genome Atlas (TCGA) breast can-
cer online portal (https://tcga-data.nci.nih.gov/docs/publications/brca_2012/;
Cancer Genome Atlas, 2012). The following files were used: for microarray
gene expression data: ‘‘BRCA.exp.547.med.txt’’ and for reverse-phase pro-
tein array expression data: ‘‘rppaData-403Samp-171Ab-Trimmed.txt.’’
Statistical Analysis
Graphpad Prism 5.0 for PC and Matlab were used for all statistical analysis.
Standard linear regression was used. Grouped analyses were performed
with Bonferroni’s test for multiple comparisons. To compare two population
distributions, chi-square and t tests were performed. Significance was estab-
lished when *p < 0.05, **p < 0.01, and ***p < 0.001.
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Supplemental Information includes Supplemental Experimental Procedures,
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Supplemental Table S1, related to Experimental Procedures: Primary cell 
strains and immortal cell lines  
*: Technical triplicates p: Passage 












160 16 1p 4p 4p
240L 19 4p 4p 4p 4p 4p 4p 4p * 4p 4p 4p 4p
168R 19 4p 4p 4p 4p 4p 4p 4p 4p 4p 4p
53R 19 1p
184 21 4p 4p 4p 4p
51R 27 1p
123 27 4p 4p 4p 4p








881P 65 4p 4p 4p 4p
122L 66 4p 4p 4p 4p 4p 4p 4p * 4p 4p 4p 4p
29 68 4p 1p 4p 4p
429ER 72 4p 4p
353P 72 4p 4p 4p 4p 4p 4p 4p 4p
464P 80 4p 4p 4p 4p 4p 4p 4p
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Figure S1, related to Experimental Procedures. (A) Representative FACS 
analyses showing CD227 and CD10 expression in fourth-passage cKit-enriched 
HMEC isolated from one woman younger than 30 years (160 16y) and (B) one 
older than 55 years (429ER 72y). Left, unstained controls; right, the CD10- and 
CD227-stained samples. 
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Figure S2, related to Figure 1 (A) Histograms represent log2-transformed ratios 
of K14 to K19 protein expression in single cells for each donor <30y under each 
condition. (B) Histograms represent log2-transformed ratios of K14 to K19 protein 
expression in single cells for each donor >55y under each condition. 
A
B
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Supplemental Table S2 related to Figure S2: p-values obtained with a Chi-squared test. 
Conditions Strain 168R 240L 184 123 124 881P 122L 353P 464P 451P
200Pa vs 500Pa 0.127 0.000 0.688 0.846 0.008 0.492 0.202 0.357 0.417 0.281
200Pa vs 1100Pa 0.054 0.003 0.010 0.096 0.000 0.459 0.235 0.162 0.166 0.124
200Pa vs 2350Pa 0.001 0.036 0.001 0.007 0.013 0.053 0.051 0.054 0.392 0.522
200Pa vs >3GPa 0.003 0.000 0.044 0.039 0.000 0.035 0.002 0.001 0.023 0.000
 
 
Figure S3, related to Figure 1. (A) Cartoon schematic of 3D encapsulation in 
click-crosslinked hyaluronic acid (HA) hydrogels. Fold change of lineage 
proportions in passage 1 cKit+ HMEC from donors (B) <30y and (C) >55y in HA 
gels with increasing stiffness.  
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Figure S4, related to Figure 1. (A) Linear regression plots of K14+/K19+ HMEC 
proportion as a function of modulus are shown for women <30y (p=0.0078, r2=
0.3327, n=5) and (B) women >55 (p=0.4002, r2= 0.0396, n=5). (C) K14+/K19+ 
HMEC proportion as a function of modulus is shown for women <30y (p=0.0101, 
n=5) and (D) women >55 (p=0.0577, n=5). Regressions and plots are fold change 
of proportions compared to 200Pa condition ± s.e.m. (E) Fold changes of 
K14+/K19+ HMEC proportion normal to 120Pa condition after 7 days of culture 
encapsulated in 3D hyaluronic acid (HA) gels (women <30y p=0.0301, n=3, F, 
women >55y p=0.0587).  
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Figure S5, related to Figure 3. Fold change of lineage proportions in cKit+ 
HMEC from women <30y and >55y on 200Pa and 2350Pa PA gels treated with 
mechano-sensing inhibitors.  
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Figure S6 related to Figure 5. (A) Correlation between YAP and TAZ gene 
expression and the protein expression of various biomarkers in TCGA dataset 
(Pearson’s r statistic is shown). (B) Correlation between YAP and TAZ gene 
expression and various biomarkers gene expression from the TCGA dataset.
A
B
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Figure S7, related to Figure 7. Growth curves for the four immortal lines used 
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Supplemental Experimental Procedures: 
Primers used for qRT-PCR: 
The primer sets were designed to target two different exons of the gene.
GAPDH  AAGGTGAAGGTCGGAGTCAAC, GGGGTCATTGATGGCAACAATA 
TEAD1 GGCCGGGAATGATTCAAACAG, CAATGGAGCGACCTTGCCA 
TEAD2 GCCTCCGAGAGCTATATGATCG, TCACTCCGTAGAAGCCACCA 
TEAD3 TCATCCACAAGCTGAAGCAC, CAATGACAAGCAGGGTCTCC 
TEAD4 GGACATCCGCCAAATCTATG,   TCCTCGATGTTGGTGTTGAG 
MST1  CCTCCCACATTCCGAAAACCA, GCACTCCTGACAAATGGGTG 
MST2  AGGAACAGCAACGAGAATTGG, CCCCTTCACTCATCGTGCTT 
LATS2  CAGCTGGAGCAAGAAATGG,     TGGCCCTCTTTAACCTGTTG 
AMOT  AGGCAAGAGTTGGAAGGATG,  TTGGAGGATGACTTCACGAG 
AMOTL1        TGCATGTGAGAAGCGAGAAC,   CATTGTATTCCGGCATGTTG 
AMOTL2        ACCATGCGGAACAAGATGGAC, GGCGGCGATTTGCAGATTC 
CTGF              CGGGTTACCAATGACAACG,   TGGAGATTTTGGGAGTACGG 
3D encapsulation in Hyaluronic Acid (HA) gels - Passage 1 cKit+ HMEC were encapsulated 
in click-crosslinked HA hydrogels (Figure S3A). Details will be published elsewhere, but 
briefly, HA-dibenzocyclooctyne (HA-DBCO) was synthesized as follows: HA-COOH (65 kDa 
molecular weight, Lifecore Biomedical) was dissolved in water, activated by EDC/NHS (N-(3-
Dimethylaminopropyl)-N -ethylcarbodiimide/N-hydroxysuccinimide, Sigma-Aldrich) and 
reacted with DBCO-amine (Sigma-Aldrich) dissolved in dimethyl sulfoxide for 48h at room 
temperature, followed by dialysis and freeze-drying to obtain HA-DBCO with approximately 
10% of the HA disaccharide units modified by DBCO (from 1H NMR data, not shown). HA-
DBCO was crosslinked by ‘click’ chemistry using bifunctional PEG-azide (1 kDa molecular 
weight, Creative Pegworks) to form hydrogels rapidly via the Strain-Promoted Azide-Alkyne 
Cycloaddition (SPAAC) reaction (Ning, Guo et al. 2008). The elastic modulus of the hydrogels 
was modified similar to that described previously (Ananthanarayanan, Kim et al. 2011) by 
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varying HA content and the ratio (r) of azide groups to HA disaccharide units. The two 
formulations chosen were 1.5 wt% HA, r = 0.15 and 3 wt% HA, r = 0.09, corresponding to 
Young’s moduli of 123 ± 37 Pa and 3843 ± 306 Pa respectively as measured by oscillatory shear 
rheology. For 3D cell encapsulation, hydrogels were prepared on glass chamber-slides treated 
with a hydrophobic solution. HA-DBCO was mixed with Collagen I (PureCol bovine collagen, 
Advanced Biomatrix) to 0.03 wt%. PEG-azide was added just prior to mixing with the cell pellet, 
and the solution was allowed to gel for 1h at 37 °C before adding media. Cell-gel constructs 
were maintained for 7d before immunofluorescent quantification of K14/K19 expression. 
Pelissier etal. Age-related dysfunction in mechanotransduction impairs differentiation of human mammary epithelial progenitors
Supplemental information 
Cell segmentation with Matlab: 
This function imports a directory of pictures, segments cells and cells incorporating EdU from 
each picture. 
Each cell from the cell mode script should be run one after each other. 
Initializing cell:
input_directory = uigetdir('C:\','Select INPUT directory');
if (input_directory == 0)
error('This directory does not exist');
end
output_directory = input_directory;












Cell number 1: Segmenting cells from a picture 
for i = 1:1:length(files)
% Name of the current picture must contain the population name (cKit,
% or unsorted) and the stiffness (L, M, H, VH, or G)
name = char(files(i).name);
% The directory should contain only pictures, if not, you can select for
% tif or lsm files.
%         if length(name) > 3
%             strin = char(name(length(name)-2:length(name)));
%             % Consider tif files only
%             if strcmp(strin, 'lsm') || strcmp(strin, 'LSM')
disp(strcat('Processing tif stack -',files(i).name,':', num2str(i),'/',...
num2str(length(files))));
The coor function finds the population (cKit or unsorted) and the condition (L, M, H, VH, G)
[position1,position2] = coor(name);
currentFile = strcat(input_directory, '/', files(i).name);
% Open the current picture
test = imread(currentFile);
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I_cy = test(:,:,4);
MyRGB = cat(3,Ired,Igreen, I_blue);
MyGray = rgb2gray(MyRGB);
MyEdU = cat(3,Ired,Igreen, I_cy);
I = MyGray;
The next step is applying a threshold to the picture




% Remove the objects under 40 pixels
bw4 = bwareaopen(bw2, 40);
Getting the perimeter of each object
bw4_perim = bwperim(bw4);
Finding the nucleus
mask_em = imextendedmax(I_blue, 20); %This value is flexible
mask_em = imfill(mask_em, 'holes');
% mask_em = bwareaopen(mask_em, 5);
Original picture showing the first 
three channels (RGB) 
Original picture converted 
to binary image using a 
threshold 
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%overlay3 = imoverlay(MyRGB, bw4_perim | mask_em, [.3 1 .3]);
%figure, imshow(overlay3);
% Compute the complement of the picture
I_eq_c = imcomplement(I);
Setting regions containing nucleus and background to a minimum
I_mod = imimposemin(I_eq_c, ~bw4 | mask_em);





stats = regionprops(L, 'Area', 'Perimeter');
Mask containing the cell 
nucleus 
Overlay of the original 
picture with the perimeter 
and the marked nucleus 
Original picture Segmented picture 
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%Green
stats_green = regionprops(L, Igreen, 'MeanIntensity', 'Area', 'Centroid');
%Red
stats_red = regionprops(L, Ired, 'MeanIntensity', 'Centroid');
%clear L_red;
Cell number 2: Segmenting cells incorporating EdU 
%EdU
bw = im2bw(I_cy, 0.2);
bw2 = imfill(bw,'holes');
bw3 = bwareaopen(bw2, 30);
figure, subplot(2,1,1), imshow(bw3) , subplot(2,1,2), imshow(I_cy);
Cell number 3: Computing the number of cells incorporating EdU: 
Labeling each object from the segmentation with mean intensitity, area and centroid properties 
stats_cy5 = regionprops(bw3, I_cy, 'Area','MeanIntensity', 'Centroid');
stats_red2 = regionprops(bw3, Ired, 'MeanIntensity', 'Centroid');
stats_green2 = regionprops(bw3, Igreen, 'MeanIntensity', 'Centroid');
% The EdU function segments cells incorporating EdU and store the red/green
% intensity ratios in a variable.
if position1==1
[EdU_cKit, n2] = EdU(EdU_cKit, n2,position2, stats_red2, stats_green2, stats_cy5);
end
if position1==2
[EdU_unso, n3] = EdU(EdU_unso, n3,position2, stats_red2, stats_green2, stats_cy5);
end
Cell number 4: Computing the results
m=1;
for k=1:length(stats_green)
% Apply a threshold against the background or unstained cells
if (stats_green(k).Area < 1000) && (stats_red(k).MeanIntensity > 40 ...
|| stats_green(k).MeanIntensity > 40)
if log2(stats_red(k).MeanIntensity / stats_green(k).MeanIntensity ) ~= -Inf ...
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&& log2(stats_red(k).MeanIntensity / stats_green(k).MeanIntensity ) ~= Inf
Computing the ratio of each cell and store the intensities










count1 = count1 +1;
end













Writing in different excel files
new_size =m;
if exist('ratio')








size= size + new_size;




%             end
%         end
end
Adapted from Steve Eddins, http://blogs.mathworks.com/steve/2006/06/02/cell-segmentation/ 
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Cell feature detection with Matlab: 
This function imports a directory of pictures and computes the homogeneity of each picture. 
Initializing cell:
input_directory = uigetdir('C:\','Select INPUT directory');
if (input_directory == 0)
error('This directory does not exist');
end
output_directory = input_directory;





Cell number 1: Computing image heterogeneity 
for i = 3:1:length(files)
% Name of the current picture must contain the population name (cKit,
% or unsorted) and the stiffness (L, M, H, VH, or G)
name = char(files(i).name);
Nmean=[];
% The directory should contain only pictures, if not, you can select for
% tif or lsm files.
%         if length(name) > 3
%             strin = char(name(length(name)-2:length(name)));
%             % Consider tif files only
%             if strcmp(strin, 'lsm') || strcmp(strin, 'LSM')
disp(strcat('Processing image -',files(i).name,':', num2str(i),'/',...
num2str(length(files))));
The coor_cyto function finds the population (cKit or unsorted)
position = coor_cyto(name);
currentFile = strcat(input_directory, '/', files(i).name);
% Open the current picture
test = imread(currentFile);
% Attribute each channel to a single picture






%In this example, we analyze F-actin homogeneity
MyRGB = cat(3,I_black,Igreen, I_blue);
MyGray = rgb2gray(MyRGB);
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I = MyGray;







Applying the graycomatrix function 
offsets = [ 0 1; 0 2; 0 3; 0 4;...
-1 1; -2 2; -3 3; -4 4;...
-1 0; -2 0; -3 0; -4 0;...
-1 -1; -2 -2; -3 -3; -4 -4];
glcms = graycomatrix(Ish,'Offset',offsets);
stats = graycoprops(glcms,'Contrast Correlation Homogeneity Energy');
Nmean=mean(stats.Homogeneity);
Adapted from MathWorks: http://www.mathworks.com/help/images/analyzing-the-texture-of-
an-image.html 
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The figure illustrates the spatial 
relationships of pixels that are defined by 
this array of offsets, where D represents 
the distance from the pixel of interest.  
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Summary
The accumulation of defective stem and progenitor cells may be common in aging tissues. This 
skewed differentiation potential is thought to impair maintenance of healthy homeostasis in 
tissues and may increase susceptibility to oncogenic events. There is not a strong age-dependent 
association with particular mutations in mammary epithelia to explain age-related cancer 
susceptibility, but there is reduction of tumor suppressive cell types and accumulation of 
defective luminal and epithelial progenitors with age. However, a quantitative understanding of 
the phenotypic and functional heterogeneity within aged tissues is lacking, which would allow us
to pinpoint subpopulations of cells that are changing during the aging process and that may be
missed in population-average experiments. We profiled the phenotype of primary human 
mammary epithelial cells from forty-four women from 16 to 91 years old using high-dimensional 
(30-parameter) mass cytometry single cell analysis. Unsupervised population partitioning 
identified a subset of luminal cells that acquired a more basal-like phenotype and accumulated
with age. The presence of luminal cells with that basal-like phenotype enabled robust 
classification of a tissue age-group. Further, increased in cytokeratin 14 and decrease in 
cytokeratin 19 with age in luminal epithelia was a specific phenotype from mass cytometry 
analysis, which we used to validate our findings by categorizing a separate cohort of normal 
breast tissue sections by age, using image analysis. We show that the etiology of these age-
related luminal cell changes was due to altered mammary luminal progenitor cells. Examination 
of a subset of the primary strains that were pushed down the malignant progression revealed that
specific marker expression signatures found in age-altered luminal cell subpopulations were 
characteristic of immortalized derivatives of older HMEC. This study presents the first high-
resolution examination of age-related phenotypic diversity of human epithelial cells and pinpoints 
specific luminal and progenitor subpopulations that are changing and accumulating with age.
Introduction
Stem cells regulate tissue homeostasis and their activity is altered with age (Biteau et al., 
2008; Mansilla et al., 2011). There is increasing evidence that dampened function of adult stem 
cells plays a role in the susceptibility to diseases of aging (reviewed in (Sharpless and DePinho, 
2007; Signer and Morrison, 2013)). In human mammary gland, differentiation defective cKit-
expressing multipotent progenitors (MPP) accumulate with age, and the proportions of their 
daughter myoepithelial cells (MEP) and luminal epithelial cells (LEP) shift with age (Garbe et 
al., 2012). The majority of age-related breast cancers are of luminal subtype (Carey et al., 2006;
Jenkins et al., 2014) and the causes for this phenotype remain elusive. We have hypothesized that 
these age-associated changes may make aged breast tissue more susceptible to malignant 
progression. We previously demonstrated that post-menopausal LEP frequently express low
levels of cytokeratin 14 (K14), as well as other markers typically associated with MEP and 
progenitors that express both K14 and K19. Moreover, age-dependent changes in the efficiency 
of YAP/TAZ-mediated mechano-transduction may help drive that phenotype of aging, as older 
progenitors do not respond to mechanical cues and more YAP has been observed in the nucleus 
of older LEP in vivo (Pelissier et al., 2014) which homolog TAZ is associated with a basal 
differentiation transcription program (Skibinski et al., 2014). We hypothesized that with age the 
luminal population retains distinct attributes reflective of an incomplete cell differentiation. Thus, 
with age, luminal cells may acquire a phenotypic divergence that is the result of age-related cell-
to-cell variability in protein levels in luminal cells.
Analysis of this cellular heterogeneity requires a multiparametric single cell-level
approach to quantify marker proteins and intracellular cell signaling changes representative of 
different cell states. Standard immunofluorescence and flow cytometry methods are limited to 
relatively few parameters (Bendall et al., 2012). Mass cytometry is a recent technology that 
allows high-dimensional analysis of single cells in complex heterogeneous biological systems
(Bandura et al., 2009). Signaling pathways, cell cycle state, cell viability, using platinum-based 
viability reagent (Fienberg et al., 2012) and many other cellular pathways can be simultaneously 
interrogated (Bendall et al., 2011).  Mass cytometry increases the number of parameters that can 
be measured, reduces overlap between channels and eliminates background fluorescence 
(Bandura et al., 2009) due to the use of isotopically pure metal labelled antibodies (Lou et al., 
2007).
In this study, we applied mass cytometry methods to measure the phenotypic
heterogeneity in forty-four primary human mammary epithelial cell (HMEC) samples from 
women aged 16 to 91 years old (y). We developed a panel of twenty-nine antibodies recognizing 
proteins and protein-modifications reflective of the epithelial phenotypic cell hierarchy together 
with markers of cell migration, cell growth, proliferation and apoptosis. To analyze the vast data,
a dimensionality-reduction strategy using t-distributed stochastic neighbor embedding (tSNE) 
(Amir el et al., 2013) and PhenoGraph were run to visualize and partition high-dimensional 
single-cell data into subpopulations (Levine et al., 2015). Additionally, unsupervised
identification of stratifying subpopulations that changed with age were analyzed using Citrus
(Bruggner et al., 2014). This comprehensive analysis revealed an unprecedented high definition 
determination of lineage-dependent heterogeneity in normal HMEC. Strikingly, unsupervised 
population partitioning revealed age-dependent clusters only within the luminal compartment.
The aged luminal cells manifested a marker expression signature that correlated with an enhanced
basal phenotype. Using this data-set we built an unsupervised classification model that correctly 
assigned more than 80% of the samples into their correct age-group. Further, we found age-
related changes in luminal progenitor cells, supporting the notion of accumulated age-altered
stem/progenitor cell populations during aging. Hence, high-dimensional analysis of normal 
human mammary epithelial cells revealed a remarkable age-related phenotypic divergence in the 
luminal and luminal progenitor cells.
Results
High dimensional analysis of human mammary epithelia from women <30y
We used mass cytometry to obtain single-cell proteomic profiles of cryopreserved normal 
primary human mammary epithelial tissue (HMEC) at passage 4 from forty-four women from 16 
to 91 years old (y) (Fig 1 and Table S1). We selected 10 highly informative luminal, 
myoepithelial and progenitor surface markers that captured the lineage-heterogeneity in HMEC
according to previous work (Asiedu et al., 2014; dos Santos et al., 2013; Hebbard et al., 2000;
LaBarge et al., 2007; Lim et al., 2009b; Louderbough et al., 2011; Rubin and Yarden, 2001;
Taylor-Papadimitriou et al., 1989; Villadsen et al., 2007). We added 12 antibody probes against 
intracellular protein phosphorylation-epitopes, 4 antibody probes against proteins of the Hippo 
pathway and 3 antibody probes against cell cycle and apoptosis proteins, thus allowing 
simultaneous measurement of surface phenotype and signaling behavior in single HMEC cells
(Figure S1 and Table S2). The complete data-set contained single cells from women from three 
age-groups (<30y N=16, >30<50y N=13 and >50y N=15) measured in 29 simultaneous protein 
epitope dimensions (D) (Fig 1A). To visualize the single cell relationships, we used tSNE to
project all 29 dimensions in 2D by a non-linear dimensionality reduction. Each dot on the tSNE 
map represents a single cell with similarity represented by a geometrical distance, such that
phenotypically related cells are close together (Fig 1B). Highlighting each marker expression 
revealed distinct LEP (K19+/K7+/K8/18+/CD133+) and MEP (K14+/K5/6+) populations in 
woman <30y (Fig 2A). Several signaling markers were perceptibly lineage-dependent: CD44, 
YAP, phospho-(p)EGFR, pStat1, pS6 and p-Phospholipase C Gamma 2 (pPLC 2) that have been 
previously implicated in myoepithelial function and contractility (Chan et al., 2012; Fu et al., 
2015; Haricharan and Li, 2014; Hebbard et al., 2000; Louderbough et al., 2011; Pasic et al., 2011;
Paszek et al., 2005; Raymond et al., 2011; Reversi et al., 2005; Vlug et al., 2013; Zhao et al., 
2010). In order to exhibit lineage-dependent markers in younger women, LEP and MEP 
populations were manually gated (gating strategy is depicted in Fig 1B). As expected, K19, K7, 
K8/18, CD133 and cKit expression was higher in LEP and K14, K5/6 expression was higher in 
MEP (Figure 2B). LEP had also higher MST1, LATS1, and MST2 expression correlating with a 
decreased YAP expression. which has been shown to 
be involved mammary epithelial proliferation and branching in a mouse model (Brantley et al., 
2001).
pCreb, pMEK1/2, pErk1/2, pAkt pStat1, pStat3 and pStat5 which have been implicated in 
myoepithelial homeostasis (Barash, 2006; Dembowy et al., 2015; Dietze et al., 2005; Gallego et 
al., 2001; Tumaneng et al., 2012; Watson, 2006). Similar phenotypic space representation was
observed in older women (Fig S2 and S3) although qualitative differences were already 
perceptible. The most prominent age-related difference was observed in the LEP population 
where YAP expression increased significantly (Fig S3A, linear regression p=0.0179, data not 
shown). Thus, high dimensional reduction analysis revealed inter-lineage heterogeneity with an 
unprecedented dimensional level and a qualitatively perceptible age-related phenotypic 
divergence between HMEC from women <30y and HMEC from older women.
Intra-lineage and age-related phenotypic divergence in the HMEC landscape 
Next we delved further into the phenotypic heterogeneity within each LEP and MEP population.
We noted “patches” of K14, K5/6, pRb and CyclinB1 expression within the MEP lineage 
suggesting the existence of distinct subpopulations (Fig 2A). To better investigate this, we 
applied PhenoGraph to automatically identify intra-lineage subpopulations (Fig 3A). The 
PhenoGraph analysis generated distinct phenotypic clusters within each lineage. LEP and MEP
cell subpopulations (clusters) were identified by characteristic cytokeratin expression and tSNE
phenotypic projection (Fig 3B). One population, denoted double positive (DP), that co-expressed
K14 and K19 was identified between LEP and MEP populations in a separate phenotypic space.
This DP population represents multipotent progenitors as previously observed in vivo (Villadsen 
et al., 2007). The last subpopulation consisted of unknown cells with low marker expression
(<0.52 ion counts per cell). Only LEP3 was more proliferative than the others according to higher 
levels of pRb and/or CyclinB1 (Giacinti and Giordano, 2006; Jin et al., 1998), while clusters 
MEP 2, 4, 7 and 8 expressed higher levels of pRb and/or CyclinB1 that correlated with higher 
DNA content (data not shown) than the other MEP subpopulations. Similar gene expression
profiles were observed in older women (data not shown). However, increased K14 expression
and decreased K19 expression was observed with age in the LEP subpopulations (Fig 3C and 
3D). Age-related changes in marker expression were observed, mainly in the LEP subpopulations
(Fig 3D). In addition, the abundance of each LEP subpopulation increased, while the abundance 
of each MEP subpopulation decreased with age (Fig 3E). This trend was observed at the 
individual level, although we observed high inter-sample heterogeneity (Fig 3F). Thus, high 
dimensional analysis revealed age-specific phenotypic divergence in specific subpopulations
comprising both cell number and marker expression.
Evidence of age-dependent phenotypic divergence in the luminal population
As the number of clusters obtained by PhenoGraph analysis was user-defined, we sought to 
further investigate age-dependent changes in an unsupervised manner. We used a hierarchical 
agglomerative clustering, characterization and regression tool (Citrus) to identify age-dependent 
clusters. Briefly, the Citrus algorithm combines all samples into one aggregate data-set before 
identifying cell populations by hierarchical clustering of phenotypically similar cells. Cells are 
assigned back to the individual samples and cluster abundance is calculated. Citrus identified
seven subpopulations that were more abundant with age (Fig 4A and Fig S4). These 
subpopulations were all projected within the luminal compartment of the tSNE phenotypic 
landscape. Each had a specific marker expression signature (Fig 4B): all of them were K14high,
cluster A was K19low and was at the apex of the hierarchy. Thus, with age there is an overall 
accumulation of luminal cells with basal characteristics. Clusters B, C and D had the highest 
pAkt, pERK1/2, pMEK1/2, pStat1, pStat3, and pStat5 expression. Most of these markers are 
associated with proliferation, migration and are mainly expressed in young MEP. Cluster B with 
the highest pRb and CyclinB1 expression which correlated with higher DNA content (data not 
shown) was “Proliferative LEP”, Cluster C was labeled “basal LEP” while cluster D, “pS6 
luminal” had the highest pS6 expression. Cluster E was all “Keratinlow” and Cluster F was labeled 
“Keratin-low S” with respect to its southern spatial position in the tSNE map. Finally, cluster G 
had the highest Axl expression and was named “Axlhigh”. Interestingly, no evidence for age-
dependent subpopulations was observed in the myoepithelial population by this unsupervised 
analysis.
Evidence of an age-dependent functional divergence in the luminal population
Next we investigated the functional consequences of the age-related changes in the mammary 
luminal compartment. The increased basal characteristics of the older luminal cells would be 
expected to affect cell adhesion and migration characteristics. LEP and MEP were FACS-sorted 
from different HMEC strains and analyzed for cell migration kinetics by real-time impedance 
measurements. LEP isolated from women <30y migrated faster than isogenic MEP (Fig 4C) as 
expected from their less adhesive properties as compared to MEP (Cerchiari et al., 2015). LEP 
isolated from women >50y migrated much slower and a rate comparable to MEP (Fig 4C and D).
This is consistent with enhanced basal properties of aged LEP.
Derivation of an age classification model 
We used the age-related phenotypic divergence to build a classification model to test the 
hypothesis that age-related changes in marker expression from our previous statistical analysis 
will generalize to an independent data-set. More importantly, a classification model uses cross-
validation which is important in guarding against testing hypotheses suggested by the data (called 
type III errors). Using a training-set of five strains from each <30 and >50y age-group, we 
successfully assigned 13/16 women <30y, and 12/15 women >50y (Fig 4E). The classification 
performance was increased with the number of training samples (Fig S4B). Three strains <30y
were incorrectly classified as “old”. One of them, 407P is a sample obtained from peripheral 
mastectomy tissue. 172L and 240L are samples with a high proportion of LEP compared to other 
strains from young women (240L is noticeable on Fig 3F). From the >30 and <50y age-group, 6
strains were assigned to “old”: 250MK which come from milk and has a luminal phenotype, 
245AT which has an ATM heterozygote mutation, 173T which comes from a tumor, 173P and
42P which are samples from peripheral mastectomy. Finally, 60R is a sample from a 47y woman,
thus close to the older age-group. From the >50y age-group, 3 strains were assigned to “young”. 
153L is a sample with a low proportion of LEP compared to other strains from older women. 
117R, and 881P might be classification errors. Thus, most of the incorrectly assigned strains have 
a particular phenotype that likely contributed to incorrect assignment. Hence, the classification
model validated the hypothesis that subsets of luminal cells are changing with age and their 
alterations in phenotypic diversity are a hallmark of aging.
Considering that the K14highK19low cluster was at the hierarchy apex amongst age-
dependent clusters, we hypothesized that these two markers were sufficient to be used as 
classifiers to build a classification model in vivo. Human breast sections were immunostained for 
K14, K19 and DAPI (<30y N=52, >30<50y N=86 and >50y N=33) (Fig 4F), and a classification 
model was built using morphometric context (Chang et al., 2013). This computational model 
relies on cell segmentation to define different epithelial cells, which then allows assessment of 
single cell K14 and K19 levels, as well as a number of morphometric features. Next, a machine 
learning-based classification model was trained for the three age-groups (<30y, >30 <50y and 
>50y) and could correctly assign more than 50% of the samples into their correct age-group as 
compared with a random guess of 33.3% (Fig 4G). In conclusion, a subpopulation of LEP 
accumulating with age with basal characteristics in vitro was identified in vivo and age-related 
markers could be used to perform a morphometric context classification.
Evidence of age-dependent phenotypic divergence in the cKit-progenitor population
Collectively, the evidence above supported the notion that the age-related changes in the human 
mammary gland strongly affected the LEP population. We hypothesized that these age-dependent
traits are the result of concomitant changes in LEP progenitors. To test this hypothesis, cKit-
expressing luminal-biased progenitors (Lim et al., 2009a) were FACS-enriched from HMEC 
strains derived from three women <30y and three women >50y, and analyzed by mass cytometry
using twelve progenitor and lineage markers (Fig 5A). Unsupervised agglomerative clustering
identified two clusters that were more abundant with age (Fig 5B and Fig S5). These clusters 
were projected in the luminal compartment in the tSNE phenotypic space and had a specific 
marker signature (Fig 5C): cluster A was K7high while Cluster B was K19high. Both of these
displayed high expression of CD133, cKit, HER2 and YAP. Thus, subpopulations of luminal 
progenitors were more abundant with age and were identifiable via a specific marker signature.
These data support the notion that age-dependent alterations in luminal progenitors are the 
etiology of the observed changes in the luminal population.
Age-related functional response to EGF activation
To reveal age-dependent functional differences, HMEC from three <30y and three >50y women 
were treated with EGF and vanadate for 60min. At, t=0, 10, 30 and 60min cells were harvested 
and analyzed with mass cytometry using MCB and a panel of 23 antibody probes (Fig S6). LEP 
and MEP manually gated showed an activation of MEK/ERK pathway within the time-course 
(Fig S1B). However, pStat, pEGFR, pErk and pMEK signaling marker expression 
were higher in LEP from women >50y. Dimensionality reduction using tSNE revealed pEGFR 
activation at the bottom–right corner of the phenotypic map with time (Fig S6B). Thus, in both 
age-groups, a cell activation wave from the top-left to the-bottom right corner in the phenotypical 
map was observed (Fig S6C). However in HMEC derived from older women, this effect was 
enhanced, suggesting increased responsiveness to EGF. We observed that pEGFR, pMEK1/2 and 
pErk expression was higher in MEP (Fig 2A) and in the clusters of older LEP (Fig 4B). Hence, 
MEK/ERK pathway activation response was reinforced in HMEC from older women due to 
functional changes in the LEP population. 
Chronological age influenced immortalization into luminal breast cancer subtypes
Normal epithelial cells must bypass tumor-suppressive barriers to give rise to malignancies. Pre-
stasis HMEC can be efficiently immortalized in a two-step process that bypasses Rb function (by 
CCND1 expression or CDKN2A knockdown) and reinstates telomerase activity (by MYC 
expression) (Garbe et al., 2014). HMEC from four women of different ages were immortalized to 
assess the outcome of breast cancer-relevant changes (Lee et al., 2015). High dimensional 
analysis of six immortalized HMEC cell lines with tSNE revealed that immortalization using
overexpression of CCND1 to bypass stasis was associated with a luminal subtype while that 
immortalization using knock-down of CDKN2A was associated with a basal subtype. Strikingly,
increased HMEC age resulted in a bias toward a luminal breast cancer subtype (Fig 6A). HMEC 
immortalization is associated with large-scale changes in gene expression, genomic instability
and epigenetic reprogramming (Garbe et al., 2009; Garbe et al., 2014) that accounted for the 
inter-sample divergence in marker expression signature (Fig 6C). Strikingly, only the older 
luminal strain (122LD1MY) but not the younger luminal strain (240D1MY), exhibited also high 
expression of basal markers , pEGFR, CD44 and pGSK3. These markers 
were also found highly expressed in the subset of LEP that accumulated with age (Fig 4B).
Collectively, these results indicate that the specific marker expression signatures found in age-
altered luminal cell subpopulations were characteristic of immortalized derivatives of older 
HMEC. This is consistent with the hypothesis that accumulation of altered luminal progenitors 
and luminal cells with basal traits during mammary gland aging reflect a breast cancer 
susceptibility phenotype.
Discussion 
In this study we described the first high-dimensional phenotypic heterogeneity of normal human 
mammary epithelial cell states. Our comprehensive single cell analysis of age-related phenotypic 
divergence revealed specific protein expression changes reflecting age-related changes in 
mammary epithelial cells.  
The strongest risk factor for breast cancer is age yet there is no genetic evidence that fully 
explains this increased incidence (LaBarge et al., 2015; Stephens et al., 2012). However, there are 
age-dependent intrinsic changes in the breast epithelia. We have shown previously that 
multipotent progenitors have a differentiation defect that leads to their accumulation with age 
(Garbe et al., 2012). Their daughter LEP are not fully lineage committed and acquire a basal 
phenotype. Using a test-set with appreciable size and appropriate computational tools, we 
revealed a subset of LEP that accumulated with age with skewed differentiation and a basal 
phenotype. The older LEP are functionally more adherent to a substrate and more responsive to 
EGF stimulation. 
Age-related signatures in the luminal clusters accumulating with age show a high 
expression of the basal marker K14. Decreased luminal K19 expression with age was a second 
marker forming the basis for a classification model that robustly assigned most samples into their
correct age-group.
Specific markers in the age-related signatures were found in clusters of progenitors 
accumulating with age: cKit, CD133, YAP and HER2. This finding correlates with the fact that 
cKit over-expression prevents normal differentiation (Regan et al., 2012) and may explain the 
accumulation of cKit progenitors with age. CD133 was the marker which changed the most with
age. CD133 was found to be a luminal progenitor marker (Hilton et al., 2014; Raouf et al., 2008).
In addition, CD133 is expressed in certain types of breast cancer, in which CD133-positivity 
seems to identify a restricted subgroup of tumor stem cells (Wright et al., 2008). As previously 
described, YAP expression in luminal biased-progenitors might result in a luminal differentiation 
with basal traits. Moreover, over-expression of HER2 has been shown to play an important role 
in the development and progression of certain aggressive types of breast cancer (Menard et al., 
2000). More recently, a group showed that in luminal breast cancer, hormonal treatment lead to a 
reduction in estrogen receptor alpha levels promoting cancer stem cell phenotype (CD133high and 
CD44low) (Sansone et al., 2016). This results correlate well with the fact estradiol serum 
concentration decreases with age (van Landeghem et al., 1985) and we observed an increase in
CD133high and CD44low cell proportion. These cells are highly suspected for the implication as 
cells-of-origin for breast cancers. The accumulation of these cells with age represents a high
susceptibility factor for oncogenic events.
Collectively, we identified age-related markers that were used to build a classification 
model. Further investigation will be needed to determine those that are implicated in breast 
cancer progression. Thus with age, progenitors and their luminal progenies appear in altered
phenotypic states, and accumulate. Altogether, the reciprocal dynamic between the 
microenvironment and the progenitor is altered, leading to an increase selection for adaptive 
mutations and a decrease in tumor suppressive mechanisms (Henry et al., 2011).
A functional decline in stem cells is not necessarily caused by a loss of the ability to self-
renew but may also reflect an inability of stem cell progeny to properly differentiate, resulting in 
the accumulation of mis-differentiated cells and an increased potential for neoplastic 
transformation. For instance, elevated Jun N-terminal kinase (JNK) activity in intestinal stem 
cells causes a dysregulation of cell differentiation leading to a stem cell pool accumulation 
(Biteau et al., 2008). As a comparison, the number of HSCs in the bone marrow increases with 
age (Beerman et al., 2010; Beerman et al., 2013; Challen et al., 2010) with no difference in 
cycling activity (Geiger et al., 2013) and aging skews differentiation potential toward myeloid 
lineages. Intuitively, increased stem cells may seem beneficial. However, this accumulating pool 
of stem cells is functionally impaired and may be more susceptible to oncogenic events. 
In addition, the age-related marker expression signature were observed in the basal 
immortalized strains and only in the older luminal immortalized strain which have overcome 
major barriers to carcinogenesis. In conclusion, we speculate that the cells’ epigenetic states that 
are associated with aging explain these differentiation biases in young and old progenitors. If we 
assume that the epigenetic states precede malignant transformation it would help to explain the 
distribution of intrinsic subtypes described previously (Jenkins et al., 2014).
Experimental Procedures
Cell Culture – All cell culture was in M87A medium with 0.1nM oxytocin (X) and cholera toxin 
(CT) at 0.5ng/mL (Garbe et al., 2009). Primary HMEC strains were generated and maintained as 
described (Labarge et al., 2013) all tissues were obtained with proper oversight from the 
Lawrence Berkeley National Laboratory institutional review board. All the pre-stasis strains were 
used at 4th passage. Table S1 shows the strains used. For the EGF treatment time course, HMEC 
from three <30y and three >50y women were treated with EGF (Sigma E-9644 0.1 g/mL) and 
sodium orthovanadate (Sigma 13721-39-6 12.5mM) for one hour. Samples at time 0, 10min, 
30min and 60min were harvested with TrypLE, fixed with 1.6% paraformaldehyde (PFA) for 
10min at room temperature (RT) and frozen at -80°C for further analysis.
Generation of immortal cell lines – Finite lifespan HMEC from specimens 184, 240L, 122L, 
and 805P were obtained from reduction mammoplasty tissues or peripheral to mastectomy tissues 
(i.e. 805P). HMEC were grown in M87A supplemented with CT at 0.5 ng/ml, and X (Bachem) at 
0.1 nM. Retroviral vectors: The p16 shRNA was in the MSCV vector, c-Myc wsa in the pBabe–
hygro (BH2) or LXSN vector. Retroviral stocks were generated from supernatants collected in 
M87A medium. Strains 240L, 122L, and 805P at passage 3 or and 184 at passage 4 were 
transduced with MSCV-p16sh or MSCV control and selected with puromycin. At the next 
passage, after puromycin selection, the p16sh transduced cells were transduced with c-Myc 
pBabe–hygro (c-myc LXSN for 184) and selected with hygromycin. Vector only control pre-
stasis cells entered stasis at passage 12-15, whereas the immortalized lines continued to grow.
Antibodies used for analysis. Antibodies were obtained in carrier protein–free PBS and then 
prepared using the MaxPAR antibody conjugation kit (DVS Sciences) according to the 
manufacturer’s protocol. After determining the percent yield by measurement of absorbance at 
280 nm, the metal-labeled antibodies were diluted in Candor PBS Antibody Stabilization solution 
(Candor Bioscience GmbH) for long-term storage at 4 °C. Antibodies used in this study are listed 
in Table S2. Antibodies were titrated and validated beforehand using both positive and negative 
cell controls.
Flow Cytometry – HMEC at fourth passage were trypsinized and resuspended in their media. 
For enrichment of luminal epithelial, myoepithelial and progenitor lineages, anti-CD227-FITC 
(Becton Dickinson, clone HMPV, 1:50), anti-CD10-PE, (BioLegend, clone HI10a, 1:100) or anti
-CD117-PE (BioLegend, clone 104D2, 1:50), respectively were added to the media for 25 
minutes on ice, washed in PBS, and sorted using FACS Vantage DIVA (Becton Dickinson).
After sorting, progenitor cells were fixed in 1.6% PFA for 10min at RT and frozen at -80°C for 
further analysis.
Cell barcoding and antibody staining. HMEC strains were incubated with cisplatin (WR 
International, Radnor, PA, Cat# 89150-634, 25 M) for one minute to assess cell viability 
(Fienberg et al., 2012), were fixed in 1.6% PFA for 10min at RT and washed once with Cell 
Staining Media (CSM, PBS with 0.5% BSA, 0.02% NaN3 with 0.03% saponin). The cells were 
then resuspended in PBS, and DMSO stocks of the barcoding reagent were added as described 
(Bodenmiller et al., 2012; Zivanovic et al., 2014). The cells were incubated at room temperature 
for 30 min, washed three times with CSM, and then pooled into a single FACS tube for staining 
with metal-labeled antibodies for 1h at RT. A staining volume of 800 l was used (~1 × 108
cells/ml). After antibody staining, the cells were washed twice with CSM and once with PBS, and 
then incubated for 20 min at room temperature or overnight at 4°C with an iridium-containing 
intercalator (DVS Sciences) in PBS with 1.6% PFA. The cells were then washed three times with 
CSM and once with PBS, diluted with water to ~106 cells per ml, and filtered through a 40- m 
membrane just before analysis by mass cytometry.
Mass cytometry analysis. The age of the strains were not known at the time of the experiment.
Cells were analyzed on a CyTOF mass cytometer (DVS Sciences) at an event rate of ~500 cells 
per second. The settings of the instrument and the initial post-processing parameters were 
described previously (Bandura et al., 2009). For each barcoded sample several data files were 
recorded. The files were concatenated using the Cytobank concatenation tool, normalized (Finck 
et al., 2013) and debarcoded (Zunder et al., 2015).
Data analysis- After gating out viable and iridium labeled events, the data were analyzed by 
applying t-Distributed Stochastic Neighbor Embedding (tSNE). This non-linear dimensionally 
reduction technique is implemented via Barnes-Hut approximations in the Matlab toolbox cyt
(Amir el et al., 2013). In tSNE, each cell is represented as a point in high-dimensional space. 
Each dimension is one parameter (the expression level of each protein in our case). An 
optimization algorithm searches for a projection of the points from the high-dimensional space 
into two dimensions such that pairwise distances between the points are best conserved between 
the high- and low-dimensional spaces.
The unsupervised PhenoGraph algorithm in cyt has been used to group cells which are 
phenotypically similar and cluster these subpopulations using modularity optimization (Levine et 
al., 2015). tSNE and PhenoGraph were performed only on surface markers.
The Citrus toolbox in R was used to identify clusters and markers that changed in abundance with 
age (Bruggner et al., 2014) in an unsupervised manner. Therefore, clusters were identified using a 
hierarchical clustering and linked to clinical data for characterization. The minimal selected 
cluster size was 0.1% of the total analyzed data. Stratifying clusters were learned by using 
regularized supervised learning methods. 
Heatmaps were obtained with Cytobank.
Classification- Using a training-set of HMEC from 5 women <30y and 5 women >50y, Citrus 
efficiently assigned most of the test-set to “young” or “old”. The training-set was changed to N=8 
to N=12 with an increased efficiency. After randomization of the training-set Citrus was not able 
to do the classification anymore, thus validating the system (data not shown).
Citrus uses nearest shrunken centroids as a predictive model to identify properties that are 
predictive of sample class. This method is implemented in the PAM package for R.
The prediction model is based on the initial training data model. Therefore, new samples are 
mapped and later assigned to the initial clusters for prediction.
Model significance- The optimal model regularization threshold was identified by using a fixed 
range of regularization thresholds. Cross-validation at each regularization threshold was used to 
estimate model error rates which were used to assess the quality of the models. Further details on 
result assessment and selection of a final regularization threshold can be found in the Citrus 
publication (Bruggner et al., 2014).
xCELLigence analysis- The lower xCELLigence chambers were filled with M87A media with 
10% FPS and the upper chamber were filled with 4x105 cells in serum-free M87 media. Cell 
Index (CI) and slopes were measured using the RTCA-DP instrument.
In vivo section staining- Paraffin-embedded tissue sections were deparaffinized and antigen-
retrieved (Vector Labs). For immunofluorescence, sections were blocked with PBS/5% normal 
goat serum/0.1% Triton X-100, and incubated with anti-K14 (1:1,000, Covance, polyclonal 
rabbit) and anti-K19 (1:20, Developmental Studies Hybridoma Bank, clone Troma-III) overnight 
at 4°C, then visualized with fluorescent secondary antibodies (Invitrogen) and imaged with a 
710LSM microscope (Carl Zeiss). Each image was represented as its Cellular Morphometric 
Context (Chang et al., 2013), which was constructed as the histogram of cellular morphometric 
subtypes derived from the cellular morphometric features (K14/K19 signals) through K-Means
(dictionary size =1024). Homogeneous kernel map (Vedaldi and Zisserman, 2012) was then 
applied on the Cellular Morphometric Context representation, so that linear support vector 
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Figure 1. Mass Cytometry Analysis of Human Mammary Epithelial Cells (HMEC). (A)
Summary of experimental design. (B) Strategy to analyze high-dimensional single-cell data and 
identify lineage and age-related phenotypic divergence. See also Figure S1.
Figure 2. Luminal and Myoepithelial Lineages Exhibit a Phenotypic Divergence. (A) tSNE 
maps from HMEC from women <30y (merged, N=16). Each dot represents one cell in the 
phenotypic space. The closer the distance between two cells, the more phenotypically similar.
The marker expression is ranged from the lowest (blue) to the highest (red). (B) Log2 fold change 
in marker expression of LEP over MEP manually gated from tSNE projection map. Student t-test 
* p<0.05 N=16. See also Figure S2 and S3.
Figure 3. Age-Related Phenotypic Divergence in the Landscape of HMEC. (A) Heatmaps of
marker expression in each clusters identified with automatic cell partitioning with PhenoGraph of 
HMEC from women <30y (merged, N=16). A stronger color indicates a higher marker 
expression. (B) tSNE projection of the clusters identified with PhenoGraph. Each cluster is color-
coded, and the same color code is used in the other figure panels. (C) Heatmaps of marker 
expression in each clusters identified with PhenoGraph of HMEC from women >30 and <50y and 
women >50y (D).  Data was normalized to values from <30y women to highlight age-related 
changes. Four abnormal samples were excluded from the analysis: a sample from milk fluid 
(250MK), two samples bearing BRCA1 or ATM mutation (90P and 245AT), and one sample 
from a tumor (173T). The fold change of marker expression is ranged from the lowest (blue) to 
the highest (red). (E) Plots of cell percentage in each cluster. Four abnormal samples we 
excluded: 250MK, 90P and 245AT, 173T. (F) Intra-sample heterogeneity for each woman is 
represented graphically by a horizontal bar in which segment lengths represent the proportion of 
the sample assigned to each cluster, colored accordingly. The two horizontal bars represent the 
age of 30 and 50y. 250MK was excluded from the analysis.
Figure 4. Evidence of Age-Dependent Phenotypic Divergence in the Luminal Population.
The Citrus algorithm combines all samples into one aggregate data-set before identifying cell 
populations by hierarchical clustering of phenotypically similar cells. Next, cells are assigned 
back to the individual samples and cluster abundance is calculated. Four abnormal samples we 
excluded: a sample from milk fluid (250MK), two samples bearing BRCA1 or ATM mutation 
(90P and 245AT), and one sample from a tumor (173T). (A) Boxplots of cell abundance in each 
cluster for each age-group and its representative tSNE phenotypic projection. (B) Heatmaps of 
marker expression in each cluster normalized to LEP from <30y women. (C) Graphs show cell 
migration index (CI) measured with xCELLigence instrument in FACS sorted LEP and MEP 
from women <30y and women >50y (N=3, p=0.045). (D) Plots show the fold change of LEP CI 
migration slope normalized to MEP CI migration slope in women <30y and >50y (N=3, Student
t-test p=0.024). (E) Citrus classification using a training-set of five women <30y and five women 
>50y. (F) Representative human breast sections immunostained for K14 (red), K19 (green) and 
DAPI (blue) from a 32y woman (left panel) and a 67y woman (right panel). The arrows point to 2 
clusters of K14+/K19+ cells (G) Plots show classification performance of breast sections from 
171 women (<30y N=52, >30<50y N=86 and >50y N=33) analyzed using morphometric context
with increasing training set size. See also Figure S4.
Figure 5. Evidence of Age-dependent Phenotypic Divergence in HMEC progenitors. (A) 
tSNE maps from cKit FACS-enriched HMEC progenitors from three women <30y and three 
women >50y. The marker expression is ranged from the lowest (blue) to the highest (red). (B) 
Boxplots of cell abundance in age-dependent clusters identified with Citrus and their
representative tSNE spatial projection. (C) Heatmaps of marker expression in each cluster 
compared to the background. See also Figure S5.
Figure 6. Chronological age influenced immortalization into luminal subtype. (A) tSNE
maps of eight immortalized strains are shown. Each color represents a strain. (B) Five selected 
marker are shown (K19, K4, K7, Axl and YAP) to illustrate phenotypic diversity. The marker 
expression is ranged from the lowest (blue) to the highest (red). (C) Heatmap of marker 
expression of each strain.
Table S1. Cell strains analyzed. HMEC strains were derived from reduction mammoplasty 
(RM), peripheral non-tumor regions from mastectomy (P) tissues, milk fluids (Milk) and a tumor 
(T). The name of the strain, the age at the time of surgery and the characteristics are indicated.
Table S2. Antibody panel. A panel of 29 antibodies is shown, comprising 10 highly informative 
surface markers, 12 antibody probes against intracellular phosphorylation, 4 antibody probes 
against the Hippo pathway and 3 antibody probes against cell cycle and apoptosis pathway. Each 
antibody clone, supplier, epitope and conjugated isotope is indicated. All the antibodies have 
been previously validated and titrated. References for relevant pathways in the regulation of 
HMEC are indicated. 
Figure S1. Validation of the Antibody Panel. The antibody panel has been extensively 
validated and titrated (data not shown). (A) Scatter plots show the antibody staining in women 
<30y (merged, N=16) to reveal the signal quality of each marker, ranging from 100 to 104 ion 
counts per cell. (B) Heatmaps of marker expression in HMEC from three <30y and >50y women 
treated with EGF and vanadate for 60min, then manually gated after tSNE projection. At, t=0, 10, 
30 and 60min cells were harvested and analyzed with mass cytometry using MCB and a panel of 
23 antibody probes. The fold change of marker expression is ranged from the lowest (green) to 
the highest (red). This experiment validates the signaling pathway antibodies.
Figure S2. Luminal and Myoepithelial Lineages Exhibit a Phenotypic Divergence in women 
>30 and <50y. (A) tSNE maps from HMEC from women >30y and <50y (merged, N=9). Four 
abnormal samples we excluded: a sample from milk fluid (250MK), two samples bearing 
BRCA1 or ATM mutation (90P and 245AT), and one sample from a tumor (173T). The marker 
expression is ranged from the lowest (blue) to the highest (red). (B) Log2 fold change in marker 
expression of LEP over MEP manually gated from tSNE. Some differential marker expression 
were not significant due to a lower sample number (N=9) in addition to age-related changes.
Student t-test * p<0.05 N=9.
Figure S3. Luminal and Myoepithelial Lineages Exhibit a Phenotypic Divergence in women 
>50y. (A) tSNE maps from HMEC from women >50y (merged, N=15). The marker expression is 
ranged from the lowest (blue) to the highest (red). (B) Log2 fold change in marker expression of 
LEP over MEP manually gated from tSNE. Student t-test * p<0.05 N=15.
Figure S4. Evidence of Age-Dependent Phenotypic Divergence in Luminal Subpopulations.
(A) Hierarchical tree of agglomerative clusters. A circle represents a cell cluster. Bubbles show 
main marker expression in the different parts of the tree. Clusters accumulating with age were in 
the luminal branch of the tree. (B) Citrus classification performance using 8, 10 or 12 training 
samples.
Figure S5. Evidence of Age-Dependent Phenotypic Divergence in the in the cKit-progenitor
population. Hierarchical tree of agglomerative clusters. A circle represents a cell cluster.
Bubbles show main marker expression in the different parts of the tree. The two clusters 
accumulating with age are shown.
Figure S6. Age-related functional response to EGF activation. HMEC from three <30y and 
>50y women were treated with EGF and vanadate for 60min. At, t=0, 10, 30 and 60min cells 
were harvested and analyzed with mass cytometry using MCB and a panel of 23 antibody probes.
(A) Heatmaps of marker expression in LEP and MEP manually gated after tSNE projection. Data 
was normalized to values from <30y women to highlight age-related changes. The log2 fold 
change is ranged from the lowest (blue) to the highest (red). (B) tSNE maps of HMEC from 
women <30y at t=0, 10, 30 and 60min. pEGFR expression is shown to highlight the movement of 
HMEC in the phenotypical space upon EGF activation. (C) Density plots in the tSNE phenotypic 
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Sample Age, y Source
Known characteristics/ 
pathology notes
48R 16 RM African-American
160 16 RM
407P 19 P IDC, lymph node+, ER+, PR+
240L 19 RM Mildly hyperplastic
168R 19 RM African-American
399E 20 RM Benign
184 21 RM
356E 21 RM Normal







Mild periductal mastitis (R+L), 
focal microcalcification (R.)
172L 28 RM





Sample Age, y Source
Known characteristics/ 
pathology notes
42P 30 P IDC, lymph node-
169L 35 RM
90P 36 P BRCA-1 mut (185delAG)
250MK 37 Milk
100P 39 P




ATM heterozygote, tissue was 
clinically normal tissue
173P 45 P





Women >30y and <50y





Slight fibrocystic disease, 
hypertrophy, stromal fibrosis, 
and adenosis present in 
mammary parenchyma
117R 56 RM










metaplasia of ductal epithelium
cystic dilatia of ducts, and focal 
areas of intraductal hyperplasia
881P 65 P
96R 66 RM Slight focal fibrocystic change
29 68 RM
353P 72 P










against Pathway References Clone Supplier
ER 170 K14 Total Myoepithelial marker (Villadsen et al., 2007) polyclonal Thermo
PR 141 K5/6 Total Myoepithelial marker (LaBarge et al., 2007) D5 Millipore
DY 163 K19 Total Luminal marker (Villadsen et al., 2007) TromaIII DSHB
DY164 K7 Total Luminal marker (Taylor-Papadimitriou et al., 1989) RCK105 BD
YB 174 K8/18 Total Luminal marker (Villadsen et al., 2007) C51 CST
YB 173 CD133 Total, epitope 1 Luminal marker  (dos Santos et al., 2013) AC133 Miltenyi
GD 161 cKit Total Progenitor marker (Lim et al., 2009; Regan etal., 2012) 104D2 Biolegend
ER 168 Axl Total Stemness (Asiedu et al., 2014) 1H12 BergenBio
GD 160 CD44 Total, surface Stemness, migration
(Hebbard et al., 2000; Louderbough 
et al., 2011) IM7 BD
HO 165 HER2 C terminal 1242-1255  Proliferation (Rubin, Yarden, 2001; Yarden, 2011) 3B5 BD
ER 167 YAP C terminal 379-407 Hippo (Zhao et al., 2010; Vlug et al., 2013) H9 Santa Cruz
ND148 MST1 aa475-505 Hippo (Zhao et al., 2010) polyclonal LS-Bio
SM149 LATS1 N-terminus Hippo (Zhao et al., 2010) polyclonal LS-Bio
DY 162 MST2 Total Hippo (Zhao et al., 2010) polyclonal LS-Bio
LA 139 pCreb pS133 Survival (Dietze et al., 2005) J151-21 BD
ND 144 pMEK1/2 pS221 Myoepithelial contractility (Pasic et al., 2011) 166F8 CST
ND 145 pStat3 pY705 Involution (Haricharan and Li, 2014) 4/pStat3 BD
ND 146 pStat5 pY694 Lobuloalveolar development (Gallego et al., 2001; Barash, 2006) 47 BD
ND150 pNFkB pS529 Mammary gland morphogenesis (Brantley et al., 2001) K10-895.12.50 BD
EU 151 pEGFR pY1068 Myoepithelial contractility
(Pasic et al., 2011; Paszek et al., 
2005) Y38 Abcam
SM152 pStat1 pY701 Tumor suppressor
(Chan et al., 2012; Haricharan and Li, 
2014). 4a BD
EU 153 pAkt pS473 Survival (Watson, 2006) D9E CST
SM 154 pErk1/2 pT202/pY204 Myoepithelial contractility (Pasic et al., 2011) 20A BD
GD 158 pGsk3 pS9 (Inactivation) Milk synthesis and cell proliferation (Dembowy et al., 2015) D85E12 CST
TM169 pPLCgamma2 pY759 Myoepithelial contractility
 (Raymond et al., 2011; Reversi et al., 
2005) K86-689.37 BD
YB 171 pS6 pS235/pS236 Survival
(Fu et al. 2015; Tumaneng et al. 
2012) N7-548 BD
GD156 Cyclin B1 Total Proliferation (Jin et al., 1998) GNS-11 BD
LU 175 pRb pS807/811 Proliferation (Giacinti and Giordano, 2006) D20B12 CST
YT 172
Cleaved 
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A   K14-high/K19-low
G   Axl-high   
C   Basal LEP 
B   Proliferative LEP
D   pS6 luminal
E   Keratin-low




K5/6, K14, pMEK1/2, 
pStat1, pStat3, pStat5, 
pNFkB, pEGFR, pAkt, 
pGSK3, CD44, YAP, 
pS6, Axl, MST2
pRb
pCreb, K5/6, K14, LATS1, 
pNFkB, pStat1, pAkt, 
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Log2 Ratio of Medians 
by Women <30y
A
-2   -1.5    -1   -0.5    0     0.5     1    1.5    2
C
